WO2024130110A1 - Home care compositions - Google Patents
Home care compositions Download PDFInfo
- Publication number
- WO2024130110A1 WO2024130110A1 PCT/US2023/084275 US2023084275W WO2024130110A1 WO 2024130110 A1 WO2024130110 A1 WO 2024130110A1 US 2023084275 W US2023084275 W US 2023084275W WO 2024130110 A1 WO2024130110 A1 WO 2024130110A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sodium
- home care
- care composition
- sulfate
- cocoyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 197
- 229940061720 alpha hydroxy acid Drugs 0.000 claims abstract description 35
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims abstract description 34
- 239000003755 preservative agent Substances 0.000 claims abstract description 25
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 23
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 23
- 239000002280 amphoteric surfactant Substances 0.000 claims abstract description 22
- 230000002335 preservative effect Effects 0.000 claims abstract description 19
- 239000004094 surface-active agent Substances 0.000 claims abstract description 17
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 72
- 150000003839 salts Chemical class 0.000 claims description 69
- -1 lauryl ether carboxylic acid Chemical class 0.000 claims description 54
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 42
- 239000011734 sodium Substances 0.000 claims description 29
- 229910052708 sodium Inorganic materials 0.000 claims description 28
- 235000015165 citric acid Nutrition 0.000 claims description 24
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 23
- 239000004310 lactic acid Substances 0.000 claims description 21
- 235000014655 lactic acid Nutrition 0.000 claims description 21
- 229940083542 sodium Drugs 0.000 claims description 19
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 claims description 14
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 11
- 239000002562 thickening agent Substances 0.000 claims description 11
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 10
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 8
- 239000011591 potassium Substances 0.000 claims description 8
- 229910052700 potassium Inorganic materials 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 7
- 150000002191 fatty alcohols Chemical class 0.000 claims description 7
- 229940040102 levulinic acid Drugs 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 6
- 229910019142 PO4 Inorganic materials 0.000 claims description 6
- 235000021317 phosphate Nutrition 0.000 claims description 6
- 229960003975 potassium Drugs 0.000 claims description 6
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 5
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 5
- 229920001525 carrageenan Polymers 0.000 claims description 5
- 239000001630 malic acid Substances 0.000 claims description 5
- 235000011090 malic acid Nutrition 0.000 claims description 5
- 229920000058 polyacrylate Polymers 0.000 claims description 5
- 235000002906 tartaric acid Nutrition 0.000 claims description 5
- 239000011975 tartaric acid Substances 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 4
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 claims description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 4
- 229940073499 decyl glucoside Drugs 0.000 claims description 4
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 235000010980 cellulose Nutrition 0.000 claims description 3
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 claims description 3
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 claims description 3
- 229940057950 sodium laureth sulfate Drugs 0.000 claims description 3
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 3
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 claims description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 3
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 239000001904 Arabinogalactan Substances 0.000 claims description 2
- 229920000189 Arabinogalactan Polymers 0.000 claims description 2
- 229920002148 Gellan gum Polymers 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 claims description 2
- 235000019312 arabinogalactan Nutrition 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 235000010492 gellan gum Nutrition 0.000 claims description 2
- 239000000216 gellan gum Substances 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims 8
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 5
- QNAYBMKLOCPYGJ-UHFFFAOYSA-M alaninate Chemical compound CC(N)C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-M 0.000 claims 4
- TUBPSFQENHCYBW-HVDRVSQOSA-N (2s)-2-aminopentanedioic acid;2-[bis(2-hydroxyethyl)amino]ethanol Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OCCN(CCO)CCO TUBPSFQENHCYBW-HVDRVSQOSA-N 0.000 claims 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims 2
- BBOPKBHSDDSVFS-UHFFFAOYSA-N 1-chloro-4-ethoxy-2-fluorobenzene Chemical compound CCOC1=CC=C(Cl)C(F)=C1 BBOPKBHSDDSVFS-UHFFFAOYSA-N 0.000 claims 2
- CYPKANIKIWLVMF-UHFFFAOYSA-N 2-[(2-oxo-3,4-dihydro-1h-quinolin-5-yl)oxy]acetic acid Chemical compound N1C(=O)CCC2=C1C=CC=C2OCC(=O)O CYPKANIKIWLVMF-UHFFFAOYSA-N 0.000 claims 2
- BMYCCWYAFNPAQC-UHFFFAOYSA-N 2-[dodecyl(methyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCN(C)CC(O)=O BMYCCWYAFNPAQC-UHFFFAOYSA-N 0.000 claims 2
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 claims 2
- 108010077895 Sarcosine Proteins 0.000 claims 2
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 claims 2
- 229940063953 ammonium lauryl sulfate Drugs 0.000 claims 2
- FMBMJZOGMAKBLM-UHFFFAOYSA-N azane;sulfo dodecanoate Chemical compound [NH4+].CCCCCCCCCCCC(=O)OS([O-])(=O)=O FMBMJZOGMAKBLM-UHFFFAOYSA-N 0.000 claims 2
- MKHVZQXYWACUQC-UHFFFAOYSA-N bis(2-hydroxyethyl)azanium;dodecyl sulfate Chemical compound OCCNCCO.CCCCCCCCCCCCOS(O)(=O)=O MKHVZQXYWACUQC-UHFFFAOYSA-N 0.000 claims 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims 2
- 229940079779 disodium cocoyl glutamate Drugs 0.000 claims 2
- 229940079868 disodium laureth sulfosuccinate Drugs 0.000 claims 2
- 229940079886 disodium lauryl sulfosuccinate Drugs 0.000 claims 2
- YGAXLGGEEQLLKV-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-2-sulfonatobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)CC(C([O-])=O)S([O-])(=O)=O YGAXLGGEEQLLKV-UHFFFAOYSA-L 0.000 claims 2
- KHIQYZGEUSTKSB-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O KHIQYZGEUSTKSB-UHFFFAOYSA-L 0.000 claims 2
- QVBODZPPYSSMEL-UHFFFAOYSA-N dodecyl sulfate;2-hydroxyethylazanium Chemical compound NCCO.CCCCCCCCCCCCOS(O)(=O)=O QVBODZPPYSSMEL-UHFFFAOYSA-N 0.000 claims 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims 2
- LAPRIVJANDLWOK-UHFFFAOYSA-N laureth-5 Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCO LAPRIVJANDLWOK-UHFFFAOYSA-N 0.000 claims 2
- 229940069822 monoethanolamine lauryl sulfate Drugs 0.000 claims 2
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims 2
- KKXWPVVBVWBKBL-UHFFFAOYSA-N n,n-diethylethanamine;dodecyl hydrogen sulfate Chemical compound CC[NH+](CC)CC.CCCCCCCCCCCCOS([O-])(=O)=O KKXWPVVBVWBKBL-UHFFFAOYSA-N 0.000 claims 2
- BOUCRWJEKAGKKG-UHFFFAOYSA-N n-[3-(diethylaminomethyl)-4-hydroxyphenyl]acetamide Chemical compound CCN(CC)CC1=CC(NC(C)=O)=CC=C1O BOUCRWJEKAGKKG-UHFFFAOYSA-N 0.000 claims 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims 2
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 229940079988 potassium cocoyl glycinate Drugs 0.000 claims 2
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 claims 2
- 229940116985 potassium lauryl sulfate Drugs 0.000 claims 2
- KYLDDUZJZSKJER-NTISSMGPSA-M potassium;(4s)-5-hydroxy-5-oxo-4-(tetradecanoylamino)pentanoate Chemical compound [H+].[K+].CCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O KYLDDUZJZSKJER-NTISSMGPSA-M 0.000 claims 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims 2
- 229940079781 sodium cocoyl glutamate Drugs 0.000 claims 2
- 229940065859 sodium cocoyl glycinate Drugs 0.000 claims 2
- 229940079776 sodium cocoyl isethionate Drugs 0.000 claims 2
- 229940045944 sodium lauroyl glutamate Drugs 0.000 claims 2
- 229940007636 sodium lauroyl methyl isethionate Drugs 0.000 claims 2
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 claims 2
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 claims 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 2
- 235000011152 sodium sulphate Nutrition 0.000 claims 2
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 claims 2
- IKGKWKGYFJBGQJ-UHFFFAOYSA-M sodium;2-(dodecanoylamino)acetate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCC([O-])=O IKGKWKGYFJBGQJ-UHFFFAOYSA-M 0.000 claims 2
- CAVXVRQDZKMZDB-UHFFFAOYSA-M sodium;2-[dodecanoyl(methyl)amino]ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CCS([O-])(=O)=O CAVXVRQDZKMZDB-UHFFFAOYSA-M 0.000 claims 2
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 claims 2
- NVIZQHFCDBQNPH-UHFFFAOYSA-M sodium;2-dodecanoyloxypropane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(C)CS([O-])(=O)=O NVIZQHFCDBQNPH-UHFFFAOYSA-M 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 2
- 229940048912 triethanolamine cocoyl glutamate Drugs 0.000 claims 2
- PWQNOLAKMCLNJI-KTKRTIGZSA-N 2-[2-[2-[(z)-octadec-9-enoxy]ethoxy]ethoxy]ethyl dihydrogen phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCOCCOCCOP(O)(O)=O PWQNOLAKMCLNJI-KTKRTIGZSA-N 0.000 claims 1
- 229940077388 benzenesulfonate Drugs 0.000 claims 1
- SHLKYEAQGUCTIO-UHFFFAOYSA-N diazanium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [NH4+].[NH4+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O SHLKYEAQGUCTIO-UHFFFAOYSA-N 0.000 claims 1
- RNPXCFINMKSQPQ-UHFFFAOYSA-N dicetyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC RNPXCFINMKSQPQ-UHFFFAOYSA-N 0.000 claims 1
- 229940093541 dicetylphosphate Drugs 0.000 claims 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 claims 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 claims 1
- MCVUKOYZUCWLQQ-UHFFFAOYSA-N n-tridecylbenzene Natural products CCCCCCCCCCCCCC1=CC=CC=C1 MCVUKOYZUCWLQQ-UHFFFAOYSA-N 0.000 claims 1
- UHGIMQLJWRAPLT-UHFFFAOYSA-N octadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCCCOP(O)(O)=O UHGIMQLJWRAPLT-UHFFFAOYSA-N 0.000 claims 1
- 229940046947 oleth-10 phosphate Drugs 0.000 claims 1
- 229940093440 oleth-3-phosphate Drugs 0.000 claims 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 claims 1
- DUXXGJTXFHUORE-UHFFFAOYSA-M sodium;4-tridecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCCC1=CC=C(S([O-])(=O)=O)C=C1 DUXXGJTXFHUORE-UHFFFAOYSA-M 0.000 claims 1
- HIEHAIZHJZLEPQ-UHFFFAOYSA-M sodium;naphthalene-1-sulfonate Chemical compound [Na+].C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1 HIEHAIZHJZLEPQ-UHFFFAOYSA-M 0.000 abstract description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 29
- 235000014113 dietary fatty acids Nutrition 0.000 description 24
- 239000000194 fatty acid Substances 0.000 description 24
- 229930195729 fatty acid Natural products 0.000 description 24
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 21
- 150000004665 fatty acids Chemical class 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 18
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 15
- 229920005862 polyol Polymers 0.000 description 15
- 150000003077 polyols Chemical class 0.000 description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 14
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 12
- 239000002585 base Substances 0.000 description 12
- 229960003237 betaine Drugs 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 11
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 10
- 150000001412 amines Chemical class 0.000 description 10
- 239000003093 cationic surfactant Substances 0.000 description 10
- 235000011121 sodium hydroxide Nutrition 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 7
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 7
- 235000013772 propylene glycol Nutrition 0.000 description 7
- 229960004063 propylene glycol Drugs 0.000 description 7
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000003086 colorant Substances 0.000 description 5
- 239000003599 detergent Substances 0.000 description 5
- 229960001484 edetic acid Drugs 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 229930182478 glucoside Natural products 0.000 description 5
- 150000002334 glycols Chemical class 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 241000894007 species Species 0.000 description 5
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 4
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 229940051250 hexylene glycol Drugs 0.000 description 4
- WPFVBOQKRVRMJB-UHFFFAOYSA-N hydroxycitronellal Chemical compound O=CCC(C)CCCC(C)(C)O WPFVBOQKRVRMJB-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- VUWCWMOCWKCZTA-UHFFFAOYSA-N 1,2-thiazol-4-one Chemical class O=C1CSN=C1 VUWCWMOCWKCZTA-UHFFFAOYSA-N 0.000 description 3
- 229940043375 1,5-pentanediol Drugs 0.000 description 3
- 244000060011 Cocos nucifera Species 0.000 description 3
- 235000013162 Cocos nucifera Nutrition 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- 244000020551 Helianthus annuus Species 0.000 description 3
- 235000003222 Helianthus annuus Nutrition 0.000 description 3
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 125000003368 amide group Chemical group 0.000 description 3
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 3
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 3
- 229940075506 behentrimonium chloride Drugs 0.000 description 3
- 229960002788 cetrimonium chloride Drugs 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 229940098691 coco monoethanolamide Drugs 0.000 description 3
- 239000007859 condensation product Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000000174 gluconic acid Substances 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 3
- 229940068041 phytic acid Drugs 0.000 description 3
- 235000002949 phytic acid Nutrition 0.000 description 3
- 239000000467 phytic acid Substances 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- YLXASPMPBDPQLL-MURFETPASA-N (9z,12z)-n-[3-(dimethylamino)propyl]octadeca-9,12-dienamide Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCCCN(C)C YLXASPMPBDPQLL-MURFETPASA-N 0.000 description 2
- UCWYGNTYSWIDSW-QXMHVHEDSA-N (z)-n-[3-(dimethylamino)propyl]octadec-9-enamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCCCN(C)C UCWYGNTYSWIDSW-QXMHVHEDSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical class CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- FKKAGFLIPSSCHT-UHFFFAOYSA-N 1-dodecoxydodecane;sulfuric acid Chemical group OS(O)(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC FKKAGFLIPSSCHT-UHFFFAOYSA-N 0.000 description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 2
- WGTDLPBPQKAPMN-KTKRTIGZSA-N 2-[2-[(z)-heptadec-8-enyl]-4,5-dihydroimidazol-1-yl]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCC1=NCCN1CCO WGTDLPBPQKAPMN-KTKRTIGZSA-N 0.000 description 2
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 2
- GHPVDCPCKSNJDR-UHFFFAOYSA-N 2-hydroxydecanoic acid Chemical compound CCCCCCCCC(O)C(O)=O GHPVDCPCKSNJDR-UHFFFAOYSA-N 0.000 description 2
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 2
- KOZZOZYINRDZOU-UHFFFAOYSA-N 2-octadecoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KOZZOZYINRDZOU-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 2
- DIJXCGXVGCADCI-UHFFFAOYSA-N 3-(docosanoylamino)propyl-trimethylazanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)C DIJXCGXVGCADCI-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- 235000011331 Brassica Nutrition 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- FKUPPRZPSYCDRS-UHFFFAOYSA-N Cyclopentadecanolide Chemical compound O=C1CCCCCCCCCCCCCCO1 FKUPPRZPSYCDRS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- 229940120146 EDTMP Drugs 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 2
- 229940069025 behenamidopropyltrimonium methosulfate Drugs 0.000 description 2
- 229940095077 behentrimonium methosulfate Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- HQKQRXZEXPXXIG-VJOHVRBBSA-N chembl2333940 Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@H]1[C@@](OC(C)=O)(C)CC2 HQKQRXZEXPXXIG-VJOHVRBBSA-N 0.000 description 2
- 239000013626 chemical specie Substances 0.000 description 2
- 229940080421 coco glucoside Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- JDRSMPFHFNXQRB-IBEHDNSVSA-N decyl glucoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IBEHDNSVSA-N 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- ZCPCLAPUXMZUCD-UHFFFAOYSA-M dihexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC ZCPCLAPUXMZUCD-UHFFFAOYSA-M 0.000 description 2
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- 229940073551 distearyldimonium chloride Drugs 0.000 description 2
- QIVLQXGSQSFTIF-UHFFFAOYSA-M docosyl(trimethyl)azanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C QIVLQXGSQSFTIF-UHFFFAOYSA-M 0.000 description 2
- HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 2
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000007046 ethoxylation reaction Methods 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- 150000003947 ethylamines Chemical class 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N ethylene glycol monomethyl ether acetate Natural products COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000002193 fatty amides Chemical class 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- 229930002839 ionone Natural products 0.000 description 2
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 2
- 229940048848 lauryl glucoside Drugs 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 229940046306 linoleamidopropyl dimethylamine Drugs 0.000 description 2
- 229960002510 mandelic acid Drugs 0.000 description 2
- 229910000000 metal hydroxide Inorganic materials 0.000 description 2
- 150000004692 metal hydroxides Chemical class 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- KVWWIYGFBYDJQC-UHFFFAOYSA-N methyl dihydrojasmonate Chemical compound CCCCCC1C(CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-UHFFFAOYSA-N 0.000 description 2
- 229940044591 methyl glucose dioleate Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229940049292 n-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 description 2
- KHPAAXRLVYMUHU-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]docosanamide Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)NCCN(CC)CC KHPAAXRLVYMUHU-UHFFFAOYSA-N 0.000 description 2
- NZXVYLJKFYSEPO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]-16-methylheptadecanamide Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)NCCCN(C)C NZXVYLJKFYSEPO-UHFFFAOYSA-N 0.000 description 2
- MNAZHGAWPCLLGX-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]docosanamide Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C MNAZHGAWPCLLGX-UHFFFAOYSA-N 0.000 description 2
- HJXPIPGLPXVLGN-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]icosanamide Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C HJXPIPGLPXVLGN-UHFFFAOYSA-N 0.000 description 2
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 2
- 229920001206 natural gum Polymers 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 235000007686 potassium Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 2
- 229940073743 steareth-20 methacrylate Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000003445 sucroses Chemical class 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- FAGMGMRSURYROS-UHFFFAOYSA-M trihexadecyl(methyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(CCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCC FAGMGMRSURYROS-UHFFFAOYSA-M 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000002888 zwitterionic surfactant Substances 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- GDIYABNICDPBCR-UHFFFAOYSA-N (1-tert-butylcyclohexyl) acetate Chemical compound CC(=O)OC1(C(C)(C)C)CCCCC1 GDIYABNICDPBCR-UHFFFAOYSA-N 0.000 description 1
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- YPZUZOLGGMJZJO-XRGAULLZSA-N (3as,5as,9as,9br)-3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1h-benzo[e][1]benzofuran Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C)[C@@H]1[C@@]2(C)OCC1 YPZUZOLGGMJZJO-XRGAULLZSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- ORTVZLZNOYNASJ-UPHRSURJSA-N (z)-but-2-ene-1,4-diol Chemical compound OC\C=C/CO ORTVZLZNOYNASJ-UPHRSURJSA-N 0.000 description 1
- CIAMOALLBVRDDK-UHFFFAOYSA-N 1,1-diaminopropan-2-ol Chemical compound CC(O)C(N)N CIAMOALLBVRDDK-UHFFFAOYSA-N 0.000 description 1
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- VDBHOHJWUDKDRW-UHFFFAOYSA-N 1-(1,1,2,3,3,6-hexamethyl-2h-inden-5-yl)ethanone Chemical compound CC1=C(C(C)=O)C=C2C(C)(C)C(C)C(C)(C)C2=C1 VDBHOHJWUDKDRW-UHFFFAOYSA-N 0.000 description 1
- RIKYKLUZQHPPQI-UHFFFAOYSA-N 1-(1,6,10-trimethylcyclododeca-2,5,9-trien-1-yl)ethanone Chemical compound CC(=O)C1(C)CCC(C)=CCCC(C)=CCC=C1 RIKYKLUZQHPPQI-UHFFFAOYSA-N 0.000 description 1
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 1
- IMRYETFJNLKUHK-SJKOYZFVSA-N 1-[(2r,3r)-1,1,2,6-tetramethyl-3-propan-2-yl-2,3-dihydroinden-5-yl]ethanone Chemical compound CC1=C(C(C)=O)C=C2[C@H](C(C)C)[C@@H](C)C(C)(C)C2=C1 IMRYETFJNLKUHK-SJKOYZFVSA-N 0.000 description 1
- AYRBHTOSHJHALD-UHFFFAOYSA-N 1-amino-2-methylpropan-1-ol Chemical compound CC(C)C(N)O AYRBHTOSHJHALD-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- BTYLJLLMYNHHNC-UHFFFAOYSA-N 1-hydroxy-1-phenylbutan-2-one Chemical compound CCC(=O)C(O)C1=CC=CC=C1 BTYLJLLMYNHHNC-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FENFUOGYJVOCRY-UHFFFAOYSA-N 1-propoxypropan-2-ol Chemical compound CCCOCC(C)O FENFUOGYJVOCRY-UHFFFAOYSA-N 0.000 description 1
- GQCZPFJGIXHZMB-UHFFFAOYSA-N 1-tert-Butoxy-2-propanol Chemical compound CC(O)COC(C)(C)C GQCZPFJGIXHZMB-UHFFFAOYSA-N 0.000 description 1
- OFHHDSQXFXLTKC-UHFFFAOYSA-N 10-undecenal Chemical compound C=CCCCCCCCCC=O OFHHDSQXFXLTKC-UHFFFAOYSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- DTKIFYHPOFQANW-UHFFFAOYSA-N 2-(2,2-dimethylhydrazinyl)ethanol Chemical compound CN(C)NCCO DTKIFYHPOFQANW-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- HRWADRITRNUCIY-UHFFFAOYSA-N 2-(2-propan-2-yloxyethoxy)ethanol Chemical compound CC(C)OCCOCCO HRWADRITRNUCIY-UHFFFAOYSA-N 0.000 description 1
- HUFRRBHGGJPNGG-UHFFFAOYSA-N 2-(2-propan-2-yloxypropoxy)propan-1-ol Chemical compound CC(C)OC(C)COC(C)CO HUFRRBHGGJPNGG-UHFFFAOYSA-N 0.000 description 1
- DJCYDDALXPHSHR-UHFFFAOYSA-N 2-(2-propoxyethoxy)ethanol Chemical compound CCCOCCOCCO DJCYDDALXPHSHR-UHFFFAOYSA-N 0.000 description 1
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- HMKKIXGYKWDQSV-SDNWHVSQSA-N 2-Pentyl-3-phenyl-2-propenal Chemical compound CCCCC\C(C=O)=C/C1=CC=CC=C1 HMKKIXGYKWDQSV-SDNWHVSQSA-N 0.000 description 1
- BDLXTDLGTWNUFM-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxy]ethanol Chemical compound CC(C)(C)OCCO BDLXTDLGTWNUFM-UHFFFAOYSA-N 0.000 description 1
- GICQWELXXKHZIN-UHFFFAOYSA-N 2-[2-[(2-methylpropan-2-yl)oxy]ethoxy]ethanol Chemical compound CC(C)(C)OCCOCCO GICQWELXXKHZIN-UHFFFAOYSA-N 0.000 description 1
- BYACHAOCSIPLCM-UHFFFAOYSA-N 2-[2-[bis(2-hydroxyethyl)amino]ethyl-(2-hydroxyethyl)amino]ethanol Chemical compound OCCN(CCO)CCN(CCO)CCO BYACHAOCSIPLCM-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- OADSZWXMXIWZSQ-UHFFFAOYSA-N 2-bromo-2-nitropropane Chemical compound CC(C)(Br)[N+]([O-])=O OADSZWXMXIWZSQ-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- KHQDWCKZXLWDNM-UHFFFAOYSA-N 2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol Chemical compound CCC(CO)=CCC1CC=C(C)C1(C)C KHQDWCKZXLWDNM-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- GMWUGZRYXRJLCX-UHFFFAOYSA-N 2-methoxypentan-2-ol Chemical compound CCCC(C)(O)OC GMWUGZRYXRJLCX-UHFFFAOYSA-N 0.000 description 1
- ZIVPLQUWOLLBNQ-UHFFFAOYSA-N 2-methyl-2-(2-propan-2-ylphenyl)propanal Chemical compound CC(C)C1=CC=CC=C1C(C)(C)C=O ZIVPLQUWOLLBNQ-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 1
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
- BJLRAKFWOUAROE-UHFFFAOYSA-N 2500-83-6 Chemical compound C12C=CCC2C2CC(OC(=O)C)C1C2 BJLRAKFWOUAROE-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- KQIGMPWTAHJUMN-UHFFFAOYSA-N 3-aminopropane-1,2-diol Chemical compound NCC(O)CO KQIGMPWTAHJUMN-UHFFFAOYSA-N 0.000 description 1
- NGYMOTOXXHCHOC-UHFFFAOYSA-N 3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pentan-2-ol Chemical compound CC(O)C(C)CCC1CC=C(C)C1(C)C NGYMOTOXXHCHOC-UHFFFAOYSA-N 0.000 description 1
- GBSGXZBOFKJGMG-UHFFFAOYSA-N 3-propan-2-yloxypropan-1-ol Chemical compound CC(C)OCCCO GBSGXZBOFKJGMG-UHFFFAOYSA-N 0.000 description 1
- ORMHZBNNECIKOH-UHFFFAOYSA-N 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde Chemical compound CC(C)(O)CCCC1=CCC(C=O)CC1 ORMHZBNNECIKOH-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- DHFUFHYLYSCIJY-WSGIOKLISA-N CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O Chemical compound CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DHFUFHYLYSCIJY-WSGIOKLISA-N 0.000 description 1
- 102000000584 Calmodulin Human genes 0.000 description 1
- 108010041952 Calmodulin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 240000008772 Cistus ladanifer Species 0.000 description 1
- 235000005241 Cistus ladanifer Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- QXKAIJAYHKCRRA-BXXZVTAOSA-N D-ribonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(O)=O QXKAIJAYHKCRRA-BXXZVTAOSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 241000191070 Escherichia coli ATCC 8739 Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000588749 Klebsiella oxytoca Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 239000004869 Labdanum Substances 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 235000015511 Liquidambar orientalis Nutrition 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 235000014150 Myroxylon pereirae Nutrition 0.000 description 1
- 244000302151 Myroxylon pereirae Species 0.000 description 1
- MFBDBXAVPLFMNJ-UHFFFAOYSA-M N,N-Bis(2-hydroxyethyl)glycine sodium salt Chemical compound [Na+].OCCN(CCO)CC([O-])=O MFBDBXAVPLFMNJ-UHFFFAOYSA-M 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- JYXGIOKAKDAARW-UHFFFAOYSA-N N-(2-hydroxyethyl)iminodiacetic acid Chemical compound OCCN(CC(O)=O)CC(O)=O JYXGIOKAKDAARW-UHFFFAOYSA-N 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- UBQYURCVBFRUQT-UHFFFAOYSA-N N-benzoyl-Ferrioxamine B Chemical compound CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN UBQYURCVBFRUQT-UHFFFAOYSA-N 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- TTZMPOZCBFTTPR-UHFFFAOYSA-N O=P1OCO1 Chemical compound O=P1OCO1 TTZMPOZCBFTTPR-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 229920001090 Polyaminopropyl biguanide Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920000289 Polyquaternium Chemical class 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 241000588777 Providencia rettgeri Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241001103617 Pseudomonas aeruginosa ATCC 15442 Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241001147691 Staphylococcus saprophyticus Species 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 239000004870 Styrax Substances 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N Tetraethylene glycol, Natural products OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- NUGMVIJLDQRNMX-UHFFFAOYSA-N [Cl-].C[NH2+]C.C[NH2+]C.C[NH2+]C.C[NH2+]C.[O-]P([O-])([O-])=O.CCCCCCCCCCCCCCCCCCC(O)C(C)O Chemical compound [Cl-].C[NH2+]C.C[NH2+]C.C[NH2+]C.C[NH2+]C.[O-]P([O-])([O-])=O.CCCCCCCCCCCCCCCCCCC(O)C(C)O NUGMVIJLDQRNMX-UHFFFAOYSA-N 0.000 description 1
- JLQNGQMMEBGCMK-UHFFFAOYSA-N [N-2]CC(C(CC(O)(O)O)O)[N-2].[K+].[K+].[K+].[K+] Chemical compound [N-2]CC(C(CC(O)(O)O)O)[N-2].[K+].[K+].[K+].[K+] JLQNGQMMEBGCMK-UHFFFAOYSA-N 0.000 description 1
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 description 1
- RXDLGFMMQFNVLI-UHFFFAOYSA-N [Na].[Na].[Ca] Chemical compound [Na].[Na].[Ca] RXDLGFMMQFNVLI-UHFFFAOYSA-N 0.000 description 1
- CDZHZLQKNAKKEC-UHFFFAOYSA-N [bis(hydroxymethylamino)methylamino]methanol Chemical compound OCNC(NCO)NCO CDZHZLQKNAKKEC-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- NJMVHBQEIKOPIT-UHFFFAOYSA-N acetic acid 2-(2-aminoethylamino)ethanol Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCNCCO NJMVHBQEIKOPIT-UHFFFAOYSA-N 0.000 description 1
- IXGIXILVXOCZSV-UHFFFAOYSA-N acetic acid;cyclohexane-1,1-diamine Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NC1(N)CCCCC1 IXGIXILVXOCZSV-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 1
- 150000005325 alkali earth metal hydroxides Chemical class 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- GUUHFMWKWLOQMM-NTCAYCPXSA-N alpha-hexylcinnamaldehyde Chemical compound CCCCCC\C(C=O)=C/C1=CC=CC=C1 GUUHFMWKWLOQMM-NTCAYCPXSA-N 0.000 description 1
- UZFLPKAIBPNNCA-BQYQJAHWSA-N alpha-ionone Chemical compound CC(=O)\C=C\C1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-BQYQJAHWSA-N 0.000 description 1
- GUUHFMWKWLOQMM-UHFFFAOYSA-N alpha-n-hexylcinnamic aldehyde Natural products CCCCCCC(C=O)=CC1=CC=CC=C1 GUUHFMWKWLOQMM-UHFFFAOYSA-N 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000010480 babassu oil Substances 0.000 description 1
- 235000001053 badasse Nutrition 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229940083979 caprylyl glucoside Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 1
- 229940026455 cedrol Drugs 0.000 description 1
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical group CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 229940047648 cocoamphodiacetate Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- BLBJUGKATXCWET-UHFFFAOYSA-N cyclaprop Chemical compound C12CC=CC2C2CC(OC(=O)CC)C1C2 BLBJUGKATXCWET-UHFFFAOYSA-N 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960000958 deferoxamine Drugs 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- YXVFQADLFFNVDS-UHFFFAOYSA-N diammonium citrate Chemical compound [NH4+].[NH4+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O YXVFQADLFFNVDS-UHFFFAOYSA-N 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 229940090960 diethylenetriamine pentamethylene phosphonic acid Drugs 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- WQABCVAJNWAXTE-UHFFFAOYSA-N dimercaprol Chemical compound OCC(S)CS WQABCVAJNWAXTE-UHFFFAOYSA-N 0.000 description 1
- 229960001051 dimercaprol Drugs 0.000 description 1
- BXLLINKJZLDGOX-UHFFFAOYSA-N dimethoxyphosphorylmethanamine Chemical compound COP(=O)(CN)OC BXLLINKJZLDGOX-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- DKJLEUVQMKPSHB-UHFFFAOYSA-N dimethyl-[3-(octadecanoylamino)propyl]-(2-oxo-2-tetradecoxyethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCCCC DKJLEUVQMKPSHB-UHFFFAOYSA-N 0.000 description 1
- OPGYRRGJRBEUFK-UHFFFAOYSA-L disodium;diacetate Chemical compound [Na+].[Na+].CC([O-])=O.CC([O-])=O OPGYRRGJRBEUFK-UHFFFAOYSA-L 0.000 description 1
- PXBZPVFAAVSLKY-UHFFFAOYSA-L disodium;hydroxy-[2-[hydroxy(oxido)phosphoryl]azepan-2-yl]phosphinate Chemical compound [Na+].[Na+].OP([O-])(=O)C1(P(O)([O-])=O)CCCCCN1 PXBZPVFAAVSLKY-UHFFFAOYSA-L 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 229940009626 etidronate Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000989 food dye Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 239000010438 granite Substances 0.000 description 1
- 229940107702 grapefruit seed extract Drugs 0.000 description 1
- 239000003722 gum benzoin Substances 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 150000002499 ionone derivatives Chemical class 0.000 description 1
- 229940075525 iron chelating agent Drugs 0.000 description 1
- 239000000797 iron chelating agent Substances 0.000 description 1
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 244000056931 lavandin Species 0.000 description 1
- 235000009606 lavandin Nutrition 0.000 description 1
- SDQFDHOLCGWZPU-UHFFFAOYSA-N lilial Chemical compound O=CC(C)CC1=CC=C(C(C)(C)C)C=C1 SDQFDHOLCGWZPU-UHFFFAOYSA-N 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 150000002692 maltoses Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000019960 monoglycerides of fatty acid Nutrition 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001157 myroxylon pereirae klotzsch resin Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- 239000002018 neem oil Substances 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical group [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- 235000019831 pentapotassium triphosphate Nutrition 0.000 description 1
- ATGAWOHQWWULNK-UHFFFAOYSA-I pentapotassium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [K+].[K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O ATGAWOHQWWULNK-UHFFFAOYSA-I 0.000 description 1
- LQPLDXQVILYOOL-UHFFFAOYSA-I pentasodium;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC(=O)[O-])CCN(CC([O-])=O)CC([O-])=O LQPLDXQVILYOOL-UHFFFAOYSA-I 0.000 description 1
- QPTMDBQLCWRDCK-UHFFFAOYSA-I pentasodium;[2-[bis[[hydroxy(oxido)phosphoryl]methyl]amino]ethyl-(phosphonatomethyl)amino]methyl-hydroxyphosphinate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].OP([O-])(=O)CN(CP(O)([O-])=O)CCN(CP(O)([O-])=O)CP([O-])([O-])=O QPTMDBQLCWRDCK-UHFFFAOYSA-I 0.000 description 1
- OSBMVGFXROCQIZ-UHFFFAOYSA-I pentasodium;[bis(phosphonatomethyl)amino]methyl-hydroxyphosphinate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].OP([O-])(=O)CN(CP([O-])([O-])=O)CP([O-])([O-])=O OSBMVGFXROCQIZ-UHFFFAOYSA-I 0.000 description 1
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940100595 phenylacetaldehyde Drugs 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229940093424 polyaminopropyl biguanide Drugs 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 235000019828 potassium polyphosphate Nutrition 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- UKHVLWKBNNSRRR-TYYBGVCCSA-M quaternium-15 Chemical compound [Cl-].C1N(C2)CN3CN2C[N+]1(C/C=C/Cl)C3 UKHVLWKBNNSRRR-TYYBGVCCSA-M 0.000 description 1
- 229940096792 quaternium-15 Drugs 0.000 description 1
- 229940032043 quaternium-52 Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000015227 regulation of liquid surface tension Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 229940048106 sodium lauroyl isethionate Drugs 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019795 sodium metasilicate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229940083982 sodium phytate Drugs 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- BRMSVEGRHOZCAM-UHFFFAOYSA-M sodium;2-dodecanoyloxyethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OCCS([O-])(=O)=O BRMSVEGRHOZCAM-UHFFFAOYSA-M 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- IWMMSZLFZZPTJY-UHFFFAOYSA-M sodium;3-(dodecylamino)propane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCNCCCS([O-])(=O)=O IWMMSZLFZZPTJY-UHFFFAOYSA-M 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 229940057981 stearalkonium chloride Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- DIORMHZUUKOISG-UHFFFAOYSA-N sulfoformic acid Chemical compound OC(=O)S(O)(=O)=O DIORMHZUUKOISG-UHFFFAOYSA-N 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 229940080258 tetrasodium iminodisuccinate Drugs 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 1
- GYBINGQBXROMRS-UHFFFAOYSA-J tetrasodium;2-(1,2-dicarboxylatoethylamino)butanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC(C([O-])=O)NC(C([O-])=O)CC([O-])=O GYBINGQBXROMRS-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- UMQCZSNKDUWJRI-UHFFFAOYSA-M tris(2-hydroxyethyl)-octadecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](CCO)(CCO)CCO UMQCZSNKDUWJRI-UHFFFAOYSA-M 0.000 description 1
- GUIWIPNQQLZJIE-UHFFFAOYSA-K tris[2-(2-hydroxyethoxy)ethyl]-octadecylazanium;phosphate Chemical compound [O-]P([O-])([O-])=O.CCCCCCCCCCCCCCCCCC[N+](CCOCCO)(CCOCCO)CCOCCO GUIWIPNQQLZJIE-UHFFFAOYSA-K 0.000 description 1
- 229940048081 trisodium ethylenediamine disuccinate Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- QEHXDDFROMGLSP-VDBFCSKJSA-K trisodium;(2s)-2-[2-[[(1s)-1-carboxy-2-carboxylatoethyl]amino]ethylamino]butanedioate Chemical compound [Na+].[Na+].[Na+].OC(=O)C[C@@H](C([O-])=O)NCCN[C@H](C([O-])=O)CC([O-])=O QEHXDDFROMGLSP-VDBFCSKJSA-K 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- FUQAYSQLAOJBBC-PAPYEOQZSA-N β-caryophyllene alcohol Chemical compound C1C[C@](C2)(C)CCC[C@]2(O)[C@H]2CC(C)(C)[C@@H]21 FUQAYSQLAOJBBC-PAPYEOQZSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/88—Ampholytes; Electroneutral compounds
- C11D1/94—Mixtures with anionic, cationic or non-ionic compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/83—Mixtures of non-ionic with anionic compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2075—Carboxylic acids-salts thereof
- C11D3/2086—Hydroxy carboxylic acids-salts thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/12—Sulfonic acids or sulfuric acid esters; Salts thereof
- C11D1/29—Sulfates of polyoxyalkylene ethers
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/662—Carbohydrates or derivatives
Definitions
- all-purpose light duty liquid or hard surface cleaning compositions have become widely accepted for cleaning hard surfaces, e.g., dishes, glasses, sinks, painted woodwork and panels, tiled walls, wash bowls, washable wallpaper, etc.
- Such all-purpose liquids comprise clear and opaque aqueous mixtures of water-soluble organic detergents and water-soluble detergent builder salts.
- a home care composition having a preservative comprising alpha hydroxy acid and/or a salt thereof; and from about 1 to about 25 wt.% of a surfactant system comprising: (i) an anionic surfactant, (ii) a non-ionic surfactant, and (iii) optionally, an amphoteric surfactant, wherein the home care composition has a Micro Robustness Index value of 0.85 or greater, and all weight percentages are based on the total weight of the home care composition.
- a home care composition having a preservative system comprising a plurality of alpha hydroxy acids and/or a salts thereof; and from about 1 to about 25 wt.% of a surfactant system comprising: (i) an anionic surfactant, (ii) a non-ionic surfactant, and (iii) optionally, an amphoteric surfactant, wherein the home care composition has a Micro Robustness Index value of 0.85 or greater, and all weight percentages are based on the total weight of the home care composition.
- FIGS. 1-3 depict bar graphs of microbial growth of bacteria within compositions prepared in accordance with aspects of the disclosure.
- ranges are used as shorthand for describing each and every value that is within the range. Any value within the range can be selected as the terminus of the range. Thus, a range from 1-5, includes specifically 1, 2, 3, 4 and 5, as well as subranges such as 2-5, 3-5, 2-3, 2-4, 1-4, etc.
- the term “about” when referring to a number means any number within a range of 10% of the number.
- the phrase “about 2 wt.%” refers to a number between and including 1.8 wt.% and 2.2 wt.%.
- the abbreviation “wt.%” means percent by weight with respect to the home care composition.
- the symbol “°” refers to a degree, such as a temperature degree or a degree of an angle.
- the symbols “h”, “min”, “mL”, “nm”, and “pm” refer to hour, minute, milliliter, nanometer, and micrometer, respectively.
- the abbreviation “rpm” means revolutions per minute.
- the symbols “C”, “H”, and “O” mean carbon, hydrogen, and oxygen, respectively.
- Volatile means having a flash point of less than about 100° C.
- Nonvolatile means having a flash point of greater than about 100° C.
- any member in a list of species that are used to exemplify or define a genus may be mutually different from, or overlapping with, or a subset of, or equivalent to, or nearly the same as, or identical to, any other member of the list of species. Further, unless explicitly stated, such as when reciting a Markush group, the list of species that define or exemplify the genus is open, and it is given that other species may exist that define or exemplify the genus just as well as, or better than, any other species listed.
- D, E, and F can be included.
- a salt thereof also relates to “salts thereof.”
- the disclosure refers to “an element selected from the group consisting of A, B, C, D, E, F, a salt thereof, and a mixture thereof,” it indicates that that one or more of A, B, C, D, and F may be included, one or more of a salt of A, a salt of B, a salt of C, a salt of D, a salt of E, and a salt of F may be included, or a mixture of any two of A, B, C, D, E, F, a salt of A, a salt of B, a salt of C, a salt of D, a salt of E, and a salt of F may be included.
- the home care compositions of the present disclosure can be free or essentially free of all components and elements positively recited throughout the present disclosure.
- the home care compositions of the present disclosure may be substantially free of non-incidental amounts of the ingredient(s) or compound(s) described herein.
- a non-incidental amount of an ingredient or compound is the amount of that ingredient or compound that is added into the home care composition by itself.
- a home care composition may be substantially free of a non-incidental amount of an ingredient or compound, although such ingredient(s) or compound(s) may be present as part of a raw material that is included as a blend of two or more compounds.
- an overlapping compound does not represent more than one component.
- certain compounds may be characterized as both a pH adjuster and an alpha hydroxy acid. If a particular home care composition includes citric acid, the citric acid will serve only as either a pH adjuster or an alpha hydroxy acid — not both.
- the chemical functional groups are in their adjective form; for each of the adjectives, the word “group” is assumed.
- the adjective “alkyl” without a noun thereafter, should be read as “an alkyl group.”
- aspects of the present invention relate to home care compositions and, particularly, home care compositions that provide improved preservative attributes.
- the home care compositions may, in many instances, provide enhanced cleaning to surfaces, are mild to human skin, and provide an enhanced reduction to bacteria and/or an enhanced inhibition to bacteria growth.
- the home care compositions include natural or naturally derived preservatives, such as an alpha hydroxy acid (e.g., citric acid, lactic acid, and/or salts thereof), while exhibiting a Micro Robustness Index value of 0.85 or greater.
- the home care composition may have a Micro Robustness Index value of about 0.9 or greater, about 1 or greater, about 1.2 or greater, about 1.4 or greater, about 1.6 or greater, about 1.7 or greater, about 1.75 or greater, about 1.8 or greater, about 1.85 or greater, or about 1.9 or greater.
- the home care compositions preferably achieve one of the above referenced Micro Robustness Index values while being substantially free of or free of isothiazolinones and/or glutaraldehyde.
- the amount of isothiazolinones in the home care composition may be about 3 wt.% or less, about 2 wt.% or less, about 1 wt.% or less, about 0.5 wt.% or less, about 0.1 wt.% or less, about 0.05 wt.% or less, about 0.01 wt.% or less, or about 0.001 wt.% or less, based on the total weight of the home care composition.
- the home care composition comprises 0 wt.% of isothiazolinones, based on the total weight of the home care composition. Additionally or alternatively, the amount of glutaraldehyde in home care composition may be about 1 ppm or less, about 0.5 ppm or less, about 0.2 ppm or less, about 0.1 ppm or less, about 0.05 ppm or less, about 0.01 ppm or less, about 0.001 ppm or less, based on the total weight of the home care composition. In at least one embodiment, the home care composition comprises 0 wt.% of glutaraldehyde, based on the total weight of the home care composition.
- the home care composition includes a preservative comprising an alpha hydroxy acid and/or a salt thereof; and from about 1 to about 25 wt.% of a surfactant system comprising: (i) an anionic surfactant, (ii) a non-ionic surfactant, and (iii) optionally, an amphoteric surfactant, wherein the home care composition has a Micro Robustness Index value of 0.85 or greater, and all weight percentages are based on the total weight of the home care composition.
- a surfactant system comprising: (i) an anionic surfactant, (ii) a non-ionic surfactant, and (iii) optionally, an amphoteric surfactant
- the home care composition comprises a preservative system comprising a plurality of alpha hydroxy acids and/or a salts thereof; and from about 1 to about 25 wt.% of a surfactant system comprising: (i) an anionic surfactant, (ii) a non-ionic surfactant, and (iii) optionally, an amphoteric surfactant, wherein the home care composition has a Micro Robustness Index value of 0.85 or greater, and all weight percentages are based on the total weight of the home care composition.
- a surfactant system comprising: (i) an anionic surfactant, (ii) a non-ionic surfactant, and (iii) optionally, an amphoteric surfactant, wherein the home care composition has a Micro Robustness Index value of 0.85 or greater, and all weight percentages are based on the total weight of the home care composition.
- the home care compositions may have a pH of about 2 to about 13.
- the pH of the home care composition is from about 2 to about 13, about 4 to about 13, about 6 to about 13, about 7 to about 13, about 9 to about 13, about 10 to about 13; from about 2 to about 11, about 4 to about 11 , about 6 to about 11 , about 7 to about 1 1 , about 9 to about 1 1 ; from about 2 to about 9, about 4 to about 9, about 6 to about 9, about 7 to about 9; from about 2 to about 7, about 4 to about 7, about 6 to about 7; from about 2 to about 6, about 4 to about 6, about 5 to about 6; about 2 to about 5, about 4 to about 5; from about 2 to about 4, about 2 to about 3, about 3 to about 4, or any range or subrange thereof.
- the home care composition may have a viscosity of from about 1 to about 100,000 mPas (cps), such as from about 25 to about 50,000 mPas (cps), about 1 to about 10,000 mPas (cps), or about 1 to about 2,000 mPas (cps), at a temperature of 25°C and a spindle no. 1 or spindle no. 2 on a Brookfield device.
- cps mPas
- the home care composition may have a viscosity of about 1 to about 2,000 mPas (cps), about 1 to about 1,500 mPas (cps), about 1 to about 1,000 mPas (cps), about 1 to about 500 mPas (cps); from about 500 to about 2,000 mPas (cps), about 500 to about 1,500 mPas (cps), about 500 to about 1,000 mPas (cps); from about 1,000 to about 2,000 mPas (cps), about 1,000 to about 1,500 mPas (cps); or from about 1,500 to about 2,000 mPas (cps) at a temperature of 25°C and a spindle no.
- the home care compositions may be in the form of soaps, surface cleaners (e.g., allpurpose surface cleaners), dish detergents, dishwasher detergents, clothing detergents, hand soaps, window cleaners, and the like.
- the home care compositions may, in some cases, have an emulsion, such as an oil-in-water or water-in-oil emulsion.
- Suitable components such as those listed below, may be included or excluded from the formulations for the home care compositions depending on the specific combination of other components, the form of the home care compositions, and/or the use of the formulation (e.g., to clean hardwood surfaces, tile surfaces, granite surfaces, window glass, pots and pans, dishes, etc.).
- the home care compositions include a preservative and/or a preservative system comprising one or more alpha hydroxy acid(s) and/or salts thereof.
- the alpha hydroxy acid(s), such as those disclosed herein, may be in the form of a salt.
- the salt of the alpha-hydroxy acid may be a sodium salt or a potassium salt.
- Non-limiting examples of alpha hydroxy acids include but are not limited to, levulinic acid, mandelic acid, glycolic acid, citric acid, lactic acid, malic acid, tartaric acid, phytic acid, hydroxycaprylic acid, hydroxycapric acid, glutaric acid, gluconic acid, or a combination of two or more thereof.
- the alpha hydroxy acid and/or a salt thereof may comprise citric acid, lactic acid, glycolic acid, malic acid, tartaric acid, levulinic acid, a salt thereof, or a combination of two or more thereof.
- the alpha hydroxy acid and/or a salt thereof is selected from citric acid, lactic acid, levulinic acid, a salt thereof, and a combination of two or more thereof.
- the preservative system comprises lactic acid and optionally another alpha hydroxy acid and/or salt thereof, such as citric acid.
- the preservative system comprises a plurality of alpha hydroxy acids and/or salts thereof.
- the preservative system may comprise 2, 3, 4, 5, 6, 7, or any range thereof, of alpha hydroxy acids.
- the home care composition may include from 2 to 5, 2 to 4, 2 or 3; from 3 to 5, 3 or 4, or 4 or 5 alpha hydroxy acids in some cases.
- the plurality of alpha hydroxy acids may comprise or consist of levulinic acid, mandelic acid, glycolic acid, citric acid, lactic acid, malic acid, tartaric acid, phytic acid, hydroxycaprylic acid, hydroxycapric acid, glutaric acid, gluconic acid, or a combination of two or more thereof.
- two or more of the plurality of alpha hydroxy acids are selected from citric acid, lactic acid, glycolic acid, malic acid tartaric acid, levulinic acid, a salt thereof, and a combination of two or more thereof.
- at least one of the plurality of alpha hydroxy acids comprises lactic acid and/or a salt thereof.
- at least one of the plurality of alpha hydroxy acids may be citric acid and/or a salt thereof.
- the plurality of alpha hydroxy acids may comprise levulinic acid and/or a salt thereof in some cases.
- the preservative system comprises lactic acid and/or a salt thereof and citric acid and/or a salt thereof.
- the preservative system may comprise lactic acid and/or a salt thereof and citric acid and/or a salt thereof, wherein the amount of lactic acid and/or a salt thereof is, preferably, from about 0.01 to about 1 wt.% about 0.01 to about 0.8 wt.%, about 0.01 to about 0.6 wt.%, about 0.01 to about 0.5 wt.%, about 0.01 to about 0.4 wt.%; from about 0.05 to about 1 wt.%, about 0.05 to about 0.8 wt.%, about 0.05 to about 0.6 wt.%, about 0.05 to about 0.5 wt.%, about 0.05 to about 0.4 wt.%; from about 0.1 to about 1 wt.% about 0.1 to about 0.8 wt.%, about 0.1 to about 0.6 wt.%, about
- the amount of citric acid and/or a salt thereof may be from about 0.05 to about 1 wt.%, about 0.05 to about 0.8 wt.%, about 0.05 to about 0.6 wt.%, about 0.05 to about 0.5 wt.%, about 0.05 to about 0.4 wt.%; from about 0.1 to about 1 wt.% about 0.1 to about 0.8 wt.%, about 0.1 to about 0.6 wt.%, about 0.1 to about 0.5 wt.%, about 0.1 to about 0.4 wt.%; from about 0.2 to about 1 wt.% about 0.2 to about 0.8 wt.%, about 0.2 to about 0.6 wt.%, about 0.2 to about 0.5 wt.%; from about 0.3 to about 1 wt.% about 0.3 to about 0.8 wt.%, about 0.3 to about 0.6 wt.%, about 0.3 to about 0.5 wt.%, from about 0.4
- the home care compositions may be formulated to comprise lactic acid and/or a salt thereof and citric acid and/or a salt thereof in a weight ratio from about 3:1 to about 1:5.
- the home care compositions have a weight ratio of lactic acid and/or a salt thereof to citric acid and/or a salt thereof of from about 3:1 to about 1:5, about 3:1 to about 1:4, about 3:1 to about 1:3, about 3:1 to about 1:2, about 3: 1 to about 1:1; from about 2:1 to about 1:5, about 2:1 to about 1:4, about 2:1 to about 1:3, about 2:1 to about 1:2, about 2:1 to about 1:1; from about 1:1 to about 1:5, about 1:1 to about 1:4, about 1:1 to about 1:3, about 1:1 to about 1:2, about 1:1, or any range or subrange thereof.
- the alpha hydroxy acid(s) and/or a salt(s) thereof may be present in the home care composition in an amount of from about 0.01 to about 15 wt.%, based on the total weight of the home care composition.
- the total amount of alpha hydroxy acid(s) and/or a salt(s) thereof present in the home care composition is from about 0.01 to about 10 wt.%, about 0.01 to about 8 wt.%, about 0.01 to about 6 wt.%, about 0.01 to about 4 wt.%, about 0.01 to about 3 wt.%, about 0.01 to about 2 wt.%, about 0.01 to about 1 wt.% about 0.01 to about 0.8 wt.%, about 0.01 to about 0.6 wt.%, about 0.01 to about 0.5 wt.%, about 0.01 to about 0.4 wt.%; from about 0.05 to about 10 wt.%, about 0.05 to about 8 wt.%,
- preservatives other than alpha hydroxy acid and/or a salt thereof may be incorporated into the home care composition.
- preservatives other than alpha hydroxy acid(s) and/or salt(s) thereof that may be incorporated into the home care composition include, but are not limited to, ethylhexylglycerin, phenoxyethanol, benzyl alcohol, parabens (such as, methylparaben, ethylparaben, propylparaben, butylparaben, isobutylparaben, etc.), sodium benzoate, ethylenediamine-tetraacetic acid (EDTA), disodium EDTA, potassium sorbate, and/or grapefruit seed extract, or combinations thereof.
- EDTA ethylenediamine-tetraacetic acid
- potassium sorbate potassium sorbate
- grapefruit seed extract or combinations thereof.
- More than one preservative may be included in the composition.
- Other preservatives include salicylic acid, DMDM hydantoin, formaldahyde, chlorphenism, triclosan, imidazolidinyl urea, diazolidinyl urea, sorbic acid, methylisothiazolinone, sodium dehydroacetate, dehydroacetic acid, Quaternium-15, stearalkonium chloride, zinc pyrithione, sodium metabisulfite, 2-bromo-2-nitropropane, chlorhexidine digluconate, polyaminopropyl biguanide, benzalkonium chloride, sodium sulfite, sodium salicylate, neem oil, essential oils (various), and Vitamin E (tocopherol).
- the cosmetic composition has a plurality of preservatives including or chosen from disodium EDTA, phenoxyethanol, ethylhexylglycerin, tocophe
- the one or more preservatives other than alpha hydroxy acid and/or a salt thereof may be present in an amount from about 0.01 to about 6 wt.%, about 0.01 to about 4 wt.%, about 0.01 to about 3 wt.%, about 0.01 to about 2 wt.%, about 0.01 to about 1 wt.% about 0.01 to about 0.8 wt.%, about 0.01 to about 0.6 wt.%, about 0.01 to about 0.5 wt.%, about 0.01 to about 0.4 wt.%; from about 0.05 to about 6 wt.%, about 0.05 to 4 wt.%, about 0.05 to about 3 wt.%, about 0.05 to about 2 wt.%, about 0.05 to about 1 wt.%, about 0.05 to about 0.8 wt.%, about 0.05 to about 0.6 wt.%, about 0.05 to about 0.5 wt.%, about 0.05 to about 0.4 wt.%
- the surfactant systems disclosed herein typically comprise two or more surfactants selected from anionic surfactants, nonionic surfactants, amphoteric surfactants, zwitterionic surfactants, and combinations of two or more thereof.
- the surfactant system may include two or more surfactants, with the two or more surfactants being chosen from different categories of anionic surfactants, nonionic surfactants, amphoteric surfactants, and zwitterionic surfactants.
- the home care composition may include from 2 to 5, 2 to 4, 2 or 3; from 3 to 5, 3 or 4, or 4 or 5 surfactants in some cases.
- the home care compositions may include one or more anionic surfactant(s) in an amount of, e.g., from about 0.5 to about 20 wt.%, based on the total weight of the home care composition.
- the amount of anionic surfactant present in the home care composition is from about 0.5 to about 20 wt.%, about 0.5 to about 15 wt.%, about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 5 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%; about 1 to about 20 wt.%, about 1 to about 15 wt.%, about 1 to about 10 wt.%, about 1 to about 8 wt.%, about 1 to about 6 wt.%, about 1 to about 5 wt.%, about 1
- Anionic surfactants that may be useful herein include water-soluble salts of alkyl sulfates and alkyl ether sulfates having from 8 to 20 carbon atoms in the alkyl group (e.g., sodium alkyl sulfate) and the water-soluble salts of sulfonated monoglycerides of fatty acids having from 8 to 20 carbon atoms.
- Sodium laurel ether sulfate (SLES), sodium lauryl sulfate, and sodium coconut monoglyceride sulfonates are examples of anionic surfactants of this type.
- anionic surfactants include sarcosinates, such as sodium lauroyl sarcosinate, laurates, sodium lauryl sulfoacetate, sodium lauroyl isethionate, sodium laureth carboxylate, and sodium dodecyl benzenesulfonate.
- the anionic surfactant comprises sodium laureth sulfate, sodium lauryl ether sulfate, sodium pareth sulfate, or a combination of two or more thereof.
- the home care composition includes sodium lauryl ether sulfate.
- the sodium lauryl ether sulfate may have an average ethoxylation of about 1 to about 5 mole per mole of lauryl ether sulfate group. In some instances, the average ethoxylation of the sodium lauryl ether sulfate is about 1 to about 4, about 1 to about 3, about 1 to about 2, or about 1 mole per mole of lauryl ether sulfate group.
- anionic surfactants can also be employed.
- anionic surfactants having a long chain (C6-C22) alkyl group such as long chain alkyl sulfates, long chain alkyl sulfonates, long chain alkyl phosphates, long chain alkyl ether sulfates, long chain alkyl alpha olefin sulfonates, long chain alkyl taurates, long chain alkyl isethionates, long chain alkyl glyceryl ether sulfonates, sulfosuccinates and the like.
- anionic surfactants having a long chain (C6-C22) alkyl group such as long chain alkyl sulfates, long chain alkyl sulfonates, long chain alkyl phosphates, long chain alkyl ether sulfates, long chain alkyl alpha olefin sulfonates, long chain alkyl taurates, long chain
- anionic surfactants can be alkoxylated, for example, ethoxylated, although alkoxylation is not required. These surfactants are typically highly water soluble as their sodium, potassium, alkyl and ammonium or alkanol ammonium containing salt form and can provide high foaming cleansing power. Other equivalent anionic surfactants may be used in some cases.
- the home care compositions may include one or more nonionic surfactant(s) in an amount that typically ranges from about 0.1 to about 10 wt.%, based on the total weight of the home care composition.
- the home care composition may include one or more nonionic surfactant(s) in an amount of from about 0.1 to about 10 wt.%, about 0.1 to about 8 wt.%, 0.1 to about 6 wt.%, about 0.1 to about 5 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%, about 0.1 to about 1 wt.%; about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 5 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2
- the nonionic surfactant may be selected from an alkanolamide, a glucoside, a fatty amine, a polyether, and a combination of two more thereof.
- the home care composition may include a glucoside selected from arachidyl glucoside, C12-20 alkyl glucoside, caprylyl/capryl glucoside, cetearyl glucoside, coco-glucoside, lauryl glucoside, decyl glucoside, or a combination of two more thereof.
- the nonionic surfactant is selected from decyl glucoside, PEG- 120 methyl glucose dioleate, coco monoethanolamide, brassica amido propyl dimethyl amine, and a combination of two more thereof. In further instances, the nonionic surfactant comprises two or more of decyl glucoside, PEG- 120 methyl glucose dioleate, coco monoethanolamide, and/or brassica amido propyl dimethyl amine.
- nonionic surfactants that may, in some cases, be suitably incorporated into the home care composition include alkylphenols and esters of fatty acids, optionally being ethoxylated, propoxylated, or glycerolated and having at least one fatty chain comprising, e.g., from 8 to 18 carbon atoms, it being possible for the number of ethylene oxide or propylene oxide groups to range from 2 to 50, and for the number of glycerol groups to range from 1 to 30. Maltose derivatives are also worth mentioning.
- nonionic surfactants include those made of copolymers of ethylene oxide and/or of propylene oxide; condensates of ethylene oxide and/or of propylene oxide with fatty alcohols; polyethoxylated fatty amides comprising, e.g., from 2 to 30 mole of ethylene oxide; polyglycerolated fatty amides comprising, e.g., from 1.5 to 5 glycerol groups, such as from 1.5 to 4; ethoxylated fatty acid esters of sorbitan comprising from 2 to 30 mole of ethylene oxide; ethoxylated oils from plant origin; fatty acid esters of sucrose; fatty acid esters of polyethylene glycol; N-(C6-C24)alkylglucamine derivatives, amine oxides such as (Cio-C 14) alkylamine oxides or N-(Cio-Ci4)acylaminopropylmorpholine oxides; and a combination of two or more thereof.
- the nonionic surfactants may, additionally or alternatively, be chosen from those broadly defined as compounds produced by the condensation of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic compound which may be aliphatic or alkyl-aromatic in nature.
- suitable nonionic surfactants include but are not limited to monoethanol amides, for example, alkyl monoethanolamides, such as cocomonoethanolamide, lauramide monoethanolamide, and the like.
- nonionic surfactants include poloxamers, polyoxyethylene, polyoxyethylene sorbitan esters, hydrogenated castor oil, fatty alcohol ethoxylates, polyethylene oxide condensates of alkyl phenols, products derived from the condensation of ethylene oxide with the reaction product of propylene oxide and ethylene diamine, ethylene oxide condensates of aliphatic alcohols, alkyl polyglycosides (e.g., fatty alcohol ethers of polyglycosides, such as fatty alcohol ethers of polyglucosides having decyl, lauryl, capryl, caprylyl, myristyl, stearyl groups; other ethers of glucose; and polyglucoside polymers, including mixed ethers such as capryl /caprylyl glucoside, coco glucoside, and lauryl glucoside), long chain tertiary amine oxides, long chain tertiary phosphine oxides, long chain dialkyl
- nonionic surfactants include polysorbate 20, long chain alkyl glucosides having C8-C22 alkyl groups; coconut fatty acid monoethanolamides, such as cocamide MEA; coconut fatty acid diethanolamides; fatty alcohol ethoxylates (alkylpolyethylene glycols); alkylphenol polyethylene glycols; alkyl mercaptan polyethylene glycols; fatty amine ethoxylates (alkylaminopolyethylene glycols); fatty acid ethoxylates (acylpolyethylene glycols); polypropylene glycol ethoxylates; fatty acid alkylolamides, (fatty acid amide polyethylene glycols); N-alkyl-, N-alkoxypolyhydroxy fatty acid amides; sucrose esters; sorbitol esters; polyglycol ethers; and combinations of two or more thereof.
- coconut fatty acid monoethanolamides such as cocamide MEA
- the home care compositions may include one or more amphoteric surfactant(s).
- the amount of amphoteric surfactants present in the home care composition may be from about 0.1 to about 10 wt.%, based on the total weight of the home care composition.
- the home care composition may include one or more amphoteric surfactant(s) in an amount of from about 0.1 to about 10 wt.%, about 0.1 to about 8 wt.%, 0.1 to about 6 wt.%, about 0.1 to about 5 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%, about 0.1 to about 1 wt.%; about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 5 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%, about 0.5 to about 1 wt.%; about 0.75 to about 10 wt.%, about 0.75 to about 8 wt.%, about 0.75 to about 6 wt.%, about 0.75
- Amphoteric surfactants are typically characterized by a combination of high surfactant activity, lather forming and mildness.
- the amphoteric surfactant may comprise a substituent containing 8 to 18 carbon atoms and a substituent containing one or more carboxylate, sulfonate, sulfate, phosphate, or phosphonate.
- the amphoteric surfactant(s) may include, but are not limited to, derivatives of aliphatic secondary and tertiary amines in which the aliphatic radical can be straight chain or branched and wherein one of the aliphatic substituents contains about 8 to about 18 carbon atoms and one contains an anionic water solubilizing group, e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate.
- anionic water solubilizing group e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate.
- examples of such compounds include sodium 3- dodecyaminopropionate, sodium 3-dodecylaminopropane sulfonate, N-alkyl taurines and N- higher alkyl aspartic acids.
- amphoteric surfactants include, but are not limited to, a range of betaines including, e.g., high alkyl betaines, such as coco dimethyl carboxymethyl betaine, lauryl dimethyl carboxy-methyl betaine, lauryl dimethyl alpha-carboxycthyl betaine, cetyl dimethyl carboxymethyl betaine, lauryl bis-(2-hydroxyethyl)carboxy methyl betaine, stearyl bis-(2- hydroxypropyl)carboxymethyl betaine, oleyl dimethyl gamma-carboxypropyl betaine, and lauryl bis-(2-hydroxypropyl)alpha-carboxyethyl betaine, sulfobetaines (such as coco dimethyl sulfopropyl betaine), stearyl dimethyl sulfopropyl betaine, amido betaines, amidosulfobetaines (such as coco dimethyl sulfopropyl betaine), steary
- Betaines having a long chain alkyl group, particularly coco may be useful as are those that include an amido group, such as the cocamidopropyl and cocoamidoethyl betaines.
- the betaine surfactant is selected from cocamidopropyl betaine, lauryl dimethyl betaine, cetyl dimethyl betaine, and cocoamphodiacetate, and a combination of two or more thereof.
- amphoteric surfactants can also be employed.
- suitable amphoteric surfactants include sultaines, also known as sulfobetaines, and hydroxy sultaines, such as cocamidopropyl hydroxy sul tain. Additional amphoteric surfactants and nonionic surfactants can be found in U.S. Pat. No. 4,051,234, which is incorporated herein in its entirety for all purposes.
- Cationic surfactants can, optionally, be included in the home care composition.
- the cationic surfactant when present, is typically included in the home care composition in an amount of from about 0.1 to about 10 wt.%, about 0.1 to about 8 wt.%, 0.1 to about 6 wt.%, about 0.1 to about 5 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%, about 0.1 to about 1 wt.%; from about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 5 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%, about 0.5 to about 1 wt.%; from about 0.75 to about 10 wt.%, about 0.75
- cationic surfactant means a surfactant that may be positively charged when it is contained in the home care compositions according to the disclosure. This surfactant may bear one or more positive permanent charges or may contain one or more functional groups that are cationizable in the home care composition according to the disclosure.
- the one or more cationic surfactants may include or be chosen from quaternary ammonium compounds, amidoamines, or a mixture of two or more thereof.
- cationic surfactants that may be suitable for the home care composition may be chosen from cetrimonium chloride, steartrimonium chloride, behentrimonium chloride, behentrimonium methosulfate, behenamidopropyltrimonium methosulfate, stearamidopropyltrimonium chloride, arachidtrimonium chloride, distearyldimonium chloride, dicetyldimonium chloride, tricetylmonium chloride, oleamidopropyl dimethylamine, linoleamidopropyl dimethylamine, isostearamidopropyl dimethylamine, oleyl hydroxyethyl imidazoline, stearamidopropyldimethylamine, behenamidoprop
- cationic surfactants include: cetyl trimethyl ammonium chloride available, stearyl trimethyl ammonium chloride, hydrogenated tallow alkyl trimethyl ammonium chloride, stearyl dimethyl benzyl ammonium chloride, stearyl propyleneglycol phosphate dimethyl ammonium chloride, stearoyl amidopropyl dimethyl benzyl ammonium chloride, stearoyl amidopropyl dimethyl (myristylacetate) ammonium chloride, and N-(stearoyl colamino formyl methy) pyridinium chloride.
- Hydrophilically substituted cationic surfactants in which at least one of the substituents contain one or more aromatic, ether, ester, amido, or amino moieties present as substituents or as linkages in the chain may also be in the home care composition.
- Non-limiting examples of hydrophilically substituted cationic surfactants that may be useful in the home care compositions include the materials having the following INCI designations: quaternium-16, quatemium-26, quatemium-27, quaternium-30, quaternium-33, quatemium-43, quaternium-52, quaternium-53, quatemium-56, quaternium-60, quaternium-61, quatemium-62, quaternium-70, quaternium-71, quatemium-72, quaternium-75, quaternium-76 hydrolyzed collagen, quaternium-77, quatemium- 78, quatemium-79 hydrolyzed collagen, quaternium-79 hydrolyzed keratin, quatemium-79 hydrolyzed milk protein, quatcrnium-79 hydrolyzed silk, quatcrnium-79 hydrolyzed soy protein, and quaternium-79 hydrolyzed
- the cationic surfactant is selected from cetrimonium chloride, stearimonium chloride, behentrimonium chloride, behentrimonium methosulfate, behenamidopropyltrimonium methosulfate, stearamidopropyltrimonium chloride, arachidtrimonium chloride, distearyldimonium chloride, dicetyldimonium chloride, tricetylmonium chloride, oleamidopropyl dimethylamine, linoleamidopropyl dimethylamine, isostearamidopropyl dimethylamine, oleyl hydroxyethyl imidazoline, stearamidopropyldimethylamine, behenamidopropyldimethylamine, behenamidopropyldiethylamine, behenamidoethyldiethyl- amine, behenamidoethyldimethylamine, ar
- the home care compositions may include one or more base(s).
- the one or more base(s), if present in the home care compositions, are typically in an amount of from about 0.01 to about 5 wt.%, based on the total weight of the home care composition.
- the home care composition may include one or more base(s) in amount of from about 0.01 to about 3 wt.%, 0.01 to about 2 wt.%, about 0.01 to about 1.5 wt.%, about 0.01 to about 1 wt.%, about 0.01 to about 0.5 wt.%; from about 0.05 to about 5 wt.%, about 0.05 to about 3 wt.%, about 0.05 to about 2 wt.%, about 0.05 to about 1.5 wt.%, about 0.05 to about 1 wt.%, about 0.05 to about 0.5 wt.%; from about 0.1 to about 5 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%, about 0.1 to about 1.5 wt.%, about 0.1 to about 1 wt.%, about 0.1 to about 0.5 wt.%; from about 0.5 to about 5 wt.%, about 0.1 to about 3 wt.%, about 0.1 to
- the one or more base(s) comprise or be selected from caustic soda, sodium hydroxide, triethanolamine, and a combination thereof.
- bases include potassium hydroxide, lye, metal hydroxide, metal hydroxide, and the like.
- the home care composition comprises caustic soda.
- the home care compositions may comprise one or more fatty acid(s) and/or neutralized derivatives thereof.
- the amount of fatty acid and/or neutralized derivatives thereof present in the home care composition may be from about 0.1 to about 30 wt.%, based on the total weight of the home care composition.
- the amount of fatty acid and/or neutralized derivatives thereof present in the home care composition is from about 0.1 to about 30 wt.%, about 0.1 to about 25 wt.%, about 0.1 to about 20 wt.%, about 0.1 to about 15 wt.%, about 0.1 to about 10 wt.%, about 0.1 to about 8 wt.%, about 0.1 to about 6 wt.%, about 0.1 to about 5 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%; from about 0.5 to about 30 wt.%, about 0.5 to about 25 wt.%, about 0.5 to about 20 wt.%, about 0.5 to about 15 wt.%, about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 5 wt.%
- the one or more fatty acids may, in some cases, may comprise myristic acid, lauric acid, palmitic acid, stearic acids, and/or other fatty acids.
- Sources of fatty acids include coconut oil, palm oil, palm kernel oil, tallow, avocado, canola, corn, cottonseed, olive, hi-oleic sunflower, mid- olcic sunflower, sunflower, palm stearin, palm kernel olein, safflower, babassu oils, and mixtures thereof.
- the fatty acids can be neutralized with a neutralizing agent, such as base, including those described herein.
- Typical bases include, but are not limited to, sodium hydroxide, potassium hydroxide, and triethanolamine.
- the home care composition is formed from fatty acids neutralized by two or more bases.
- the bases are sodium hydroxide and triethanolamine.
- the molar ratio of sodium hydroxide and triethanolamine is from about 4:1 to about 1:4, about 3:1 to about 1:3, or about 2:1 to about 1:2.
- the home care composition has a molar ratio of sodium hydroxide to triethanolamine of about 1:1.
- the home care composition may include a fatty acid comprising stearic acid and an acid comprising lauric acid.
- the amount of stearic acid based on a total weight of starting fatty acids is 60 wt.%, and the amount of lauric acid based on a total weight of starting fatty acids is 40 wt.%.
- the molar amount of fatty acids is greater than the molar amount of neutralizing agent such that fatty acid remains in the composition.
- the fatty acid may be neutralized with neutralizing agents selected from alkali metal carbonates, alkali metal phosphates, organic amines, hydroxide base compounds, and mixtures thereof, and particularly from, e.g., organic amines, alkali metal hydroxides, alkali earth metal hydroxides, and mixtures thereof.
- Organic amines may be selected from amino-2-methyl-l- propanol (or aminomethyl propanol), ethylamines, ethyleneamines, alkanolamines, cyclic amines and other cyclic compounds, saturated or unsaturated, having one or more nitrogen atoms within the ring, and mixtures thereof.
- the organic amines may be chosen from the ones having a pKb at a temperature of 25°C of less than 12, such as less than 10 or less than 6. It should be noted that this is the pKb corresponding to the function of highest basicity.
- Non-limiting examples of organic amines include organic amines comprising one or two primary, secondary, or tertiary amine functions, and at least one linear or branched Ci-Cs alkyl groups bearing at least one hydroxyl radical.
- Organic amines may also be chosen from alkanolamines, such as mono-, di- or trialkanolamines, comprising one to three identical or different C1-C4 hydroxyalkyl radicals, ethylamines, ethyleneamines, quinoline, aniline and cyclic amines, such as pyrroline, pyrrole, pyrrolidine, imidazole, imidazolidine, imidazolidinine, morpholine, pyridine, piperidine, pyrimidine, piperazine, triazinc and derivatives thereof.
- Examples of compounds of the alkanolamine type include, but are not limited to, monoethanolamine (also known as monoethanolamine or MEA), diethanolamine, triethanolamine, monoisopropanolamine, diisopropanolamine, N-dimethylaminoethanolamine, 2- amino-2-methyl-l -propanol, triisopropanolamine, 2-amino-2-methyl-l,3-propanediol, 3-amino- 1 ,2-propanediol, 3-dimethylamino-l,2-propanediol, 2-amino-2-methyl- 1 -propanol, and tris(hydroxymethylamino)methane.
- Other examples include, but are not limited to: 1,3- diaminopropane, l,3-diamino-2-propanol, spermine, and spermidine.
- the home care composition may include a thickening agent.
- the thickening agent may be included in the home care compositions in an amount from about 0.1 to about 20 wt.%, based on the total weight of the home care composition.
- the thickening agent may be present in the home care composition in an amount of from about 0.1 to about 15 wt.%, about 0.1 to about 10 wt.%, about 0.1 to about 8 wt.%, about 0.1 to about 6 wt.%, about 0.1 to about 5 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%; from about 1 to 20 wt.%, about 1 to about 15 wt.%, about 1 to about 10 wt.%, about 1 to about 8 wt.%, about 1 to about 6 wt.%, about 1 to about 5 wt.%, about 1 to about 4 wt.
- thickening agent can increase the viscosity or yield point in the home care composition.
- the thickening agents include, but are not limited to, clay, polymers, polymeric gums, polysaccharides, microfibrous cellulose, gellan gum, pectine, alginate, arabinogalactan, carageenan, xanthan gum, guar gum, rhamsan gum, furcellaran gum, and other natural gums.
- a polymer thickening agent in one embodiment is a polyacrylate.
- polyacrylates include acrylates/steareth-20 methacrylate crosspolymer, acrylates/steareth-20 methacrylate crosspolymcr, and combinations thereof.
- Non-limiting examples, of polymers that may be included as thickening agents, solely or in conjunction with other thickening agents, include polyvinyl pyrrolidone, carbomers (e.g., carboxyvinyl polymers), carrageenans (e.g., Irish moss, carrageenan, iota-carrageenan, etc.), high molecular weight polyethylene glycols, cellulosic polymers, hydroxyethylcellulose, carboxymethylcellulose, and salts thereof (e.g., CMC sodium), natural gums (e.g., karaya, xanthan, gum arabic, and tragacanth), colloidal magnesium aluminum silicate, and the like, and mixtures or combinations of two or more thereof.
- carbomers e.g., carboxyvinyl polymers
- carrageenans e.g., Irish moss, carrageenan, iota-carrageenan, etc.
- the thickening agent may, optionally, comprise gums, sucrose esters, polyvinylpyrrolidone (PVP) and co-polymers, celluloses, polyquaternium compounds, and carboxylic acid or carboxylate based homopolymer or co-polymer, which can be linear or crosslinked.
- PVP polyvinylpyrrolidone
- the home care compositions may, in some embodiments, include one or more polyol(s).
- the one or more polyol(s) may be present in the home care composition in an amount from about 0.1 to about 20 wt.%, based on the total weight of the home care composition.
- the home care compositions include one or more polyol(s) in an amount from about 0.1 to about 18 wt.%, about 0.1 to about 16 wt.%, about 0.1 to about 14 wt.%, about 0.1 to about 12 wt.%, about 0.1 to about 10 wt.%, about 0.1 to about 8 wt.%, about 0.1 to about 6 wt.%, about 0.1 to about 4 wt.%; from about 0.5 to about 20 wt.%, about 0.5 to about 18 wt.%, about 0.5 to about 16 wt.%, about 0.5 to about 14 wt.%, about 0.5 to about 12 wt.%, about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 4 wt.%; from about 1 to about 20 wt.%, about 1 to about 18 wt.%, about 1 to about 18 w
- polyol should be understood as meaning, within the meaning of the present disclosure, an organic molecule comprising at least two free hydroxyl groups.
- the polyols of the home care composition may be glycols or compounds with numerous hydroxyl groups. In some cases, the polyol(s) is selected from the group consisting of C2-C32 polyols.
- the one or more polyols may be liquid at ambient temperature (25 °C).
- the polyol(s) may have from 2 to 32 carbon atoms, from 3 to 16 carbon atoms, or from 3 to 12 carbon atoms.
- Polyols that may be included in the home care composition include ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, glycerin, diglycerin, diethylene glycol, dipropylene glycol, and combinations of two or more thereof.
- the polyol is propylene glycol.
- the polyol is one or both of propylene glycol and butylene glycol.
- Non-limiting examples of polyols that may, optionally, be included in the home care include those chosen from alkanediols, such as glycerin, 1,2,6-hexanetriol, trimethylolpropane, ethylene glycol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, pentaethylene glycol, dipropylene glycol, 2-butene- 1 ,4-diol, 2-ethyl- 1 ,3-hexanediol, 2-methyl-2,4-pentanediol, caprylyl glycol, 1 ,2-hexanediol, 1,2-pentanediol, and 4-methyl-l,2-pentanediol; glycol ethers, such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol
- the one or more polyols may, optionally, be glycols or glycol ethers such as, e.g., monomethyl, monoethyl and monobutyl ethers of ethylene glycol, propylene glycol or ethers thereof, such as, monomethyl ether of propylene glycol, butylene glycol, hexylene glycol, dipropylene glycol as well as alkyl ethers of diethylene glycol, such as monoethyl ether or monobutyl ether of diethylene glycol.
- glycols or glycol ethers such as, e.g., monomethyl, monoethyl and monobutyl ethers of ethylene glycol, propylene glycol or ethers thereof, such as, monomethyl ether of propylene glycol, butylene glycol, hexylene glycol, dipropylene glycol as well as alkyl ethers of diethylene glycol, such as monoethyl ether or monobutyl
- the one or more polyols may include or are chosen from ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, pentylene glycol, 1,3-propanediol, diethylene glycol, dipropylene glycol, 1,4-butanediol, 1,5-pentanediol, hexane- 1 ,6-diol, glycerin, diglycerin, caprylyl glycol, and a mixture of two or more thereof.
- the home care compositions may be aqueous and, e.g., include water in an amount from about 1 to about 95 wt.%, based on the total weight of the home care composition.
- the water may be present in the home care composition in an amount from about 5 to about 95 wt.%, about 10 to about 95 wt.%, about 15 to about 95 wt.%, about 20 to about 95 wt.%, about 30 to about 95 wt.%, about 40 to about 95 wt.%, about 50 to about 95 wt.%, about 60 to about 95 wt.%, about 70 to about 95 wt.%, about 80 to about 95 wt.%, about 90 to about 95 wt.%; from about 5 to about 90 wt.%, about 10 to about 90 wt.%, about 15 to about 90 wt.%, about 20 to about 90 wt.%, about 30 to about 90 wt.%, about 40 to about 90 wt.%, about 50 to about 90 wt.%, about 60 to about 90 wt.%, about 70 to about 90 wt.%, about 80 to about 90 wt.%; from about 5 to about 80
- Additional ingredients may be present in the home care composition.
- the additional ingredients may include, e.g., ingredients to preserve, emulsify, add fragrance, stabilize (e.g., chelating agents), adjust the pH, and color.
- the home care compositions may include any of the following additional ingredients in an amount of from about 0.01 to about 5 wt.%, based on the total weight of the home care composition.
- the amount of additional ingredients present in the home care composition is from about 0.01 to about 4 wt.%, about 0.01 to about 3 wt.%, about 0.01 to about 2 wt.%, about 0.01 to about 1 wt.%, about 0.01 to about 0.5 wt.%, about 0.01 to about 0.1 wt.%; from about 0.1 to about 5 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%, about 0.1 to about 1 wt.%, about 0.1 to about 0.5 wt.%, about 0.1 to about 0.1 wt.%; from about 0.5 to about 5 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%, about 0.5 to about 1 wt.%; from about 0.75 to about 5 wt.%, about 0.75
- Non-limiting examples of fragrances and perfumes include odor compounds selected from: 7-acetyl-l,2,3,4,5,6,7,8-octahydro-l,l,6,7-tetramethylnaphthalene, a-ionone, P-ionone, y- ionone a-isomcthy I ionone, methylcedrylone, methyl dihydrojasmonate, methyl 1,6,10-trimethyl- 2,5,9-cyclododecatrien-l-yl ketone, 7-acetyl-l,l,3,4,4,6-hexamethyltetralin, 4-acetyl-6-tert- buty 1-1,1 -dimethylindane, hydroxyphenylbutanone, benzophenone, methyl P-naphthyl ketone, 6- acetyl- 1 , 1 ,2,3,3,5-hexamethylindane, 5-acetyl-3-
- fragrances may include odor compounds selected from essential oils, resinoids and resins from a large number of sources, such as Peru balsam, olibanum resinoid, styrax, labdanum resin, nutmeg, cassia oil, benzoin resin, coriander, and lavandin.
- sources such as Peru balsam, olibanum resinoid, styrax, labdanum resin, nutmeg, cassia oil, benzoin resin, coriander, and lavandin.
- fragrances include odor compounds selected from phenylethyl alcohol, terpineol, linalool, linalyl acetate, geraniol, nerol, 2-(l,l-dimethylethyl)cyclo-hexanol acetate, benzyl acetate, eugenol, and a combination of two or more thereof.
- the fragrances or perfumes can be used as single substances or in a mixture with one another.
- the home care composition may further comprise one or more colorants.
- the colorants may be a pigment, a dye, or mixtures thereof.
- pigments include titanium dioxide, zinc oxide, kaolin, mica, etc.
- dyes include food dyes suitable for food, drug and cosmetic applications, and mixtures thereof.
- Some color agents (colorants) arc known as FD&C dyes.
- the colorants may be present in an amount ranging from about 0.0001 wt.% to about 0.4 wt.%, including all percentages and subranges therebetween, based on the total weight of the home care composition. In some embodiments, the colorants may be present in an amount ranging from about 0.0001 wt.% to about 4 wt.%, including all percentages and subranges therebetween, based on the total weight of the home care composition.
- Non-limiting examples of chemical chelating agents include aminotrimethyl phosphonic acid, B-alanine diacetic acid, cyclodextrin, cyclohexanediamine tetracetic acid, diethylenetriamine pentamethylene phosphonic acid, diethanolamine N-acetic acid, ethylene diamine tetracetic acid (EDTA or YH 4 ) and its sodium (YH 3 Na, Y 2 H 2 Na 2 , YHNa 3 and YNa 4 ), potassium (YH 3 K, Y 2 H 3 K 3 and YK 4 ), calcium disodium, and diammonium salts and its salts with triethanolamine (TEA- EDTA), etidronic acid, galactanic acid, hydroxyethyl ethylenediamine tetracetic acid (HEDTA) and its trisodium salt, gluconic acid, glucuronic acid, nitrilotriacetic acid (NT A) and its trisodium
- Additional iron chelating agent include those disclosed and/or claimed in the international patent application WO 94/61338, which is incorporated herein in its entirety for all purposes.
- biological chelating agents include metallothionein, transferrin, calmodulin, and sodium chitosan methylene phosphonatc.
- the home care composition may include one or more pH adjusters to increase or decrease the overall pH of the home care composition.
- one or more acids may be included to decrease the pH of the home care composition.
- suitable acids for decreasing the pH of the home care composition include, but are not limited to, citric acid, acetic acid, and the like.
- the home care composition may include one or more bases, such as sodium hydroxide, potassium hydroxide and the like, to increase the pH of the home care composition. Additional or alternative acids and bases that are suitable for adjusting the pH of the home care composition are readily known to one of ordinary skill in the art.
- compositions were prepared in the form of a surface cleaner according to aspects of the invention.
- Two non-limiting example compositions (Ex. A and Ex. B) were formulated to contain two alpha hydroxy acids, namely lactic acid and citric acid.
- Five comparative compositions (Comp. Ex. 1 to Comp. Ex. 5) were formulated to contain one alpha hydroxy acid, specifically lactic acid or citric acid.
- Example Comp. A and Comp. B and Comp. Ex. 1 to Comp. Ex. 5 included caustic soda in an amount to obtain a pH of 3 to 3.5 for the respective home care composition.
- the formulations for Ex. A and Ex. B and Comp. Ex. 1 to Comp. Ex. 5 are shown in Table 1.
- Ex. A and Ex. B and Comp. Ex. 1 to Comp. Ex 5 were evaluated to assess the microbial growth of bacteria within each composition. Specifically, Ex. A and Ex. B and Comp. Ex. 1 to Comp. Ex. 5 were evaluated using a standard Micro Robustness test and expressed on a Micro Robustness Index (“MRI”).
- MRI Micro Robustness Index
- the MRI test evaluated the microbial growth of standard bacteria pool containing: Burkholderia cepacia ATCC 10856; Enterobacter cloacae PLS 237; Escherichia coli ATCC 8739; Klebsiella oxytoca PLS 104B; Klebsiella pneumoniae PLS 113; Serratia marcescens PLS 201; Providencia rettgeri PLS 200; Pseudomonas aeruginosa ATCC 15442; Pseudomonas putida PLS 111; Staphylococcus aureus ATCC 6538; and Staphylococcus saprophyticus PLS 110B.
- A, Ex. B and Comp. Ex. 1 to Comp. Ex. 5 was inoculated by adding 1.0 mL of the bacteria inoculum at time 0 hours (first inoculation). Each inoculated sample was then thoroughly mixed using a sterile wooden stick or other sterile stirrer.
- a MRI value of 0.85 or greater is generally considered to be robust and, thus, suitable for home care compositions.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Home care compositions are disclosed herein. According to one aspect, provided is a home care composition that includes a preservative comprising an alpha hydroxy acid and/or salt thereof; and from about 1 to about 25 wt.% of a surfactant system comprising: (i) an anionic surfactant, (ii) a non-ionic surfactant, and (iii) optionally, an amphoteric surfactant; wherein the home care composition has a Micro Robustness Index value of 0.85 or greater, and all weight percentages are based on the total weight of the home care composition.
Description
HOME CARE COMPOSITIONS
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of priority from U.S. Provisional Application No. 63/433,071, filed December 16, 2022, the contents of which are hereby incorporated herein by reference in their entirety.
BACKGROUND
[0002] In recent years all-purpose light duty liquid or hard surface cleaning compositions have become widely accepted for cleaning hard surfaces, e.g., dishes, glasses, sinks, painted woodwork and panels, tiled walls, wash bowls, washable wallpaper, etc. Such all-purpose liquids comprise clear and opaque aqueous mixtures of water-soluble organic detergents and water-soluble detergent builder salts.
[0003] There is an ongoing need for improved home care products that clean, are mild to human skin, and have improved resistance to bacteria.
BRIEF SUMMARY
[0004] This summary is intended merely to introduce a simplified summary of some aspects of one or more implementations of the present disclosure. Further areas of applicability of the present disclosure will become apparent from the detailed description provided hereinafter. This summary is not an extensive overview, nor is it intended to identify key or critical elements of the present teachings, nor to delineate the scope of the disclosure. Rather, its purpose is merely to present one or more concepts in simplified form as a prelude to the detailed description below.
[0005] In accordance with an aspect of the invention, provided is a home care composition having a preservative comprising alpha hydroxy acid and/or a salt thereof; and from about 1 to about 25 wt.% of a surfactant system comprising: (i) an anionic surfactant, (ii) a non-ionic surfactant, and (iii) optionally, an amphoteric surfactant, wherein the home care composition has a Micro Robustness Index value of 0.85 or greater, and all weight percentages are based on the total weight of the home care composition.
[0006] In accordance with another aspect of the invention, provided is a home care composition having a preservative system comprising a plurality of alpha hydroxy acids and/or a salts thereof;
and from about 1 to about 25 wt.% of a surfactant system comprising: (i) an anionic surfactant, (ii) a non-ionic surfactant, and (iii) optionally, an amphoteric surfactant, wherein the home care composition has a Micro Robustness Index value of 0.85 or greater, and all weight percentages are based on the total weight of the home care composition.
BRIEF DESCRIPTION OF THE DRAWING
[0007] The features, and advantages of the invention will be apparent from the following more detailed description of certain embodiments of the invention and as illustrated in the accompanying drawings in which:
[0008] FIGS. 1-3 depict bar graphs of microbial growth of bacteria within compositions prepared in accordance with aspects of the disclosure.
[0009] It should be understood that the various aspects are not limited to the compositions, arrangements, and instrumentality shown in the figures.
DETAILED DESCRIPTION
[0010] For illustrative purposes, the principles of the present invention are described by referencing various exemplary embodiments thereof. Although certain embodiments of the invention are specifically described herein, one of ordinary skill in the art will readily recognize that the same principles are equally applicable to and can be employed in other apparatuses and methods. Before explaining the disclosed embodiments of the present invention in detail, it is to be understood that the invention is not limited in its application to the details of any particular embodiment disclosed herein. The terminology used herein is for the purpose of description and not of limitation.
[0011] As used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural references unless the context dictates otherwise. The singular form of any class of the ingredients refers not only to one chemical species within that class, but also to a mixture of those chemical species. The terms “a” (or “an”), “one or more” and “at least one” may be used interchangeably herein. The terms “comprising”, “including”, and “having” may be used interchangeably. The term “include” should be interpreted as “include, but are not limited to”. The term “including” should be interpreted as “including, but are not limited to”.
[0012] As used throughout, ranges are used as shorthand for describing each and every value that
is within the range. Any value within the range can be selected as the terminus of the range. Thus, a range from 1-5, includes specifically 1, 2, 3, 4 and 5, as well as subranges such as 2-5, 3-5, 2-3, 2-4, 1-4, etc.
[0013] The term “about” when referring to a number means any number within a range of 10% of the number. For example, the phrase “about 2 wt.%” refers to a number between and including 1.8 wt.% and 2.2 wt.%.
[0014] All references cited herein are hereby incorporated by reference in their entireties. In the event of a conflict in a definition in the present disclosure and that of a cited reference, the present disclosure controls.
[0015] The abbreviations and symbols as used herein, unless indicated otherwise, take their ordinary meaning. The abbreviation “wt.%” means percent by weight with respect to the home care composition. The symbol “°” refers to a degree, such as a temperature degree or a degree of an angle. The symbols “h”, “min”, “mL”, “nm”, and “pm” refer to hour, minute, milliliter, nanometer, and micrometer, respectively. The abbreviation “UV-VIS” referring to a spectrometer or spectroscopy, means Ultraviolet-Visible. The abbreviation “rpm” means revolutions per minute. [0016] When referring to chemical structures, and names, the symbols “C”, “H”, and “O” mean carbon, hydrogen, and oxygen, respectively. The symbols
“=” and “=” mean single bond, double bond, and triple bond, respectively.
[0017] “Volatile”, as used herein, means having a flash point of less than about 100° C. “Nonvolatile”, as used herein, means having a flash point of greater than about 100° C.
[0018] Any member in a list of species that are used to exemplify or define a genus, may be mutually different from, or overlapping with, or a subset of, or equivalent to, or nearly the same as, or identical to, any other member of the list of species. Further, unless explicitly stated, such as when reciting a Markush group, the list of species that define or exemplify the genus is open, and it is given that other species may exist that define or exemplify the genus just as well as, or better than, any other species listed.
[0019] The phrases, “a mixture thereof,” “a combination thereof,” or a combination of two or more thereof” do not require that the mixture include all of A, B, C, D, E, and F (although all of A, B,
C, D, E, and F may be included). Rather, it indicates that a mixture of any two or more of A, B, C,
D, E, and F can be included. In other words, it is equivalent to the phrase “one or more elements selected from the group consisting of A, B, C, D, E, F, and a mixture of any two or more of A, B,
C, D, E, and F.” Likewise, the term “a salt thereof’ also relates to “salts thereof.” Thus, where the disclosure refers to “an element selected from the group consisting of A, B, C, D, E, F, a salt thereof, and a mixture thereof,” it indicates that that one or more of A, B, C, D, and F may be included, one or more of a salt of A, a salt of B, a salt of C, a salt of D, a salt of E, and a salt of F may be included, or a mixture of any two of A, B, C, D, E, F, a salt of A, a salt of B, a salt of C, a salt of D, a salt of E, and a salt of F may be included.
[0020] All components and elements positively set forth in this disclosure can be negatively excluded from the claims. In other words, the home care compositions of the present disclosure can be free or essentially free of all components and elements positively recited throughout the present disclosure. In some instances, the home care compositions of the present disclosure may be substantially free of non-incidental amounts of the ingredient(s) or compound(s) described herein. A non-incidental amount of an ingredient or compound is the amount of that ingredient or compound that is added into the home care composition by itself. For example, a home care composition may be substantially free of a non-incidental amount of an ingredient or compound, although such ingredient(s) or compound(s) may be present as part of a raw material that is included as a blend of two or more compounds.
[0021] Some of the various categories of components identified may overlap. In such cases where overlap may exist and the home care composition includes both components (or the composition includes more than two components that overlap), an overlapping compound does not represent more than one component. For example, certain compounds may be characterized as both a pH adjuster and an alpha hydroxy acid. If a particular home care composition includes citric acid, the citric acid will serve only as either a pH adjuster or an alpha hydroxy acid — not both.
[0022] For readability purposes, the chemical functional groups are in their adjective form; for each of the adjectives, the word “group” is assumed. For example, the adjective “alkyl” without a noun thereafter, should be read as “an alkyl group.”
[0023] Aspects of the present invention relate to home care compositions and, particularly, home care compositions that provide improved preservative attributes. The home care compositions may, in many instances, provide enhanced cleaning to surfaces, are mild to human skin, and provide an enhanced reduction to bacteria and/or an enhanced inhibition to bacteria growth. In some embodiments, the home care compositions include natural or naturally derived preservatives, such as an alpha hydroxy acid (e.g., citric acid, lactic acid, and/or salts thereof), while exhibiting
a Micro Robustness Index value of 0.85 or greater. For example, the home care composition may have a Micro Robustness Index value of about 0.9 or greater, about 1 or greater, about 1.2 or greater, about 1.4 or greater, about 1.6 or greater, about 1.7 or greater, about 1.75 or greater, about 1.8 or greater, about 1.85 or greater, or about 1.9 or greater.
[0024] The home care compositions preferably achieve one of the above referenced Micro Robustness Index values while being substantially free of or free of isothiazolinones and/or glutaraldehyde. For example, the amount of isothiazolinones in the home care composition may be about 3 wt.% or less, about 2 wt.% or less, about 1 wt.% or less, about 0.5 wt.% or less, about 0.1 wt.% or less, about 0.05 wt.% or less, about 0.01 wt.% or less, or about 0.001 wt.% or less, based on the total weight of the home care composition. In some embodiments, the home care composition comprises 0 wt.% of isothiazolinones, based on the total weight of the home care composition. Additionally or alternatively, the amount of glutaraldehyde in home care composition may be about 1 ppm or less, about 0.5 ppm or less, about 0.2 ppm or less, about 0.1 ppm or less, about 0.05 ppm or less, about 0.01 ppm or less, about 0.001 ppm or less, based on the total weight of the home care composition. In at least one embodiment, the home care composition comprises 0 wt.% of glutaraldehyde, based on the total weight of the home care composition.
[0025] In accordance with an aspect of the invention, the home care composition includes a preservative comprising an alpha hydroxy acid and/or a salt thereof; and from about 1 to about 25 wt.% of a surfactant system comprising: (i) an anionic surfactant, (ii) a non-ionic surfactant, and (iii) optionally, an amphoteric surfactant, wherein the home care composition has a Micro Robustness Index value of 0.85 or greater, and all weight percentages are based on the total weight of the home care composition.
[0026] In accordance with another aspect of the invention, the home care composition comprises a preservative system comprising a plurality of alpha hydroxy acids and/or a salts thereof; and from about 1 to about 25 wt.% of a surfactant system comprising: (i) an anionic surfactant, (ii) a non-ionic surfactant, and (iii) optionally, an amphoteric surfactant, wherein the home care composition has a Micro Robustness Index value of 0.85 or greater, and all weight percentages are based on the total weight of the home care composition.
[0027] The home care compositions may have a pH of about 2 to about 13. In some cases, the pH of the home care composition is from about 2 to about 13, about 4 to about 13, about 6 to about 13, about 7 to about 13, about 9 to about 13, about 10 to about 13; from about 2 to about 11, about
4 to about 11 , about 6 to about 11 , about 7 to about 1 1 , about 9 to about 1 1 ; from about 2 to about 9, about 4 to about 9, about 6 to about 9, about 7 to about 9; from about 2 to about 7, about 4 to about 7, about 6 to about 7; from about 2 to about 6, about 4 to about 6, about 5 to about 6; about 2 to about 5, about 4 to about 5; from about 2 to about 4, about 2 to about 3, about 3 to about 4, or any range or subrange thereof.
[0028] Additionally or alternatively, the home care composition may have a viscosity of from about 1 to about 100,000 mPas (cps), such as from about 25 to about 50,000 mPas (cps), about 1 to about 10,000 mPas (cps), or about 1 to about 2,000 mPas (cps), at a temperature of 25°C and a spindle no. 1 or spindle no. 2 on a Brookfield device. For example, the home care composition may have a viscosity of about 1 to about 2,000 mPas (cps), about 1 to about 1,500 mPas (cps), about 1 to about 1,000 mPas (cps), about 1 to about 500 mPas (cps); from about 500 to about 2,000 mPas (cps), about 500 to about 1,500 mPas (cps), about 500 to about 1,000 mPas (cps); from about 1,000 to about 2,000 mPas (cps), about 1,000 to about 1,500 mPas (cps); or from about 1,500 to about 2,000 mPas (cps) at a temperature of 25°C and a spindle no. 1 or spindle no. 2 on a Brookfield device. The Brookfield spindle number for evaluating lower viscosities (e.g., viscosities of 1 to 1,000 cps) is typically spindle no. 2 is typically spindle no. 1, while the Brookfield spindle number for evaluating higher viscosities (e.g., viscosities of 1,001 to 2,000 cps) is typically spindle no. 2. [0029] The home care compositions may be in the form of soaps, surface cleaners (e.g., allpurpose surface cleaners), dish detergents, dishwasher detergents, clothing detergents, hand soaps, window cleaners, and the like. The home care compositions may, in some cases, have an emulsion, such as an oil-in-water or water-in-oil emulsion. Suitable components, such as those listed below, may be included or excluded from the formulations for the home care compositions depending on the specific combination of other components, the form of the home care compositions, and/or the use of the formulation (e.g., to clean hardwood surfaces, tile surfaces, granite surfaces, window glass, pots and pans, dishes, etc.).
[0030] The home care compositions include a preservative and/or a preservative system comprising one or more alpha hydroxy acid(s) and/or salts thereof. The alpha hydroxy acid(s), such as those disclosed herein, may be in the form of a salt. The salt of the alpha-hydroxy acid may be a sodium salt or a potassium salt. Non-limiting examples of alpha hydroxy acids include but are not limited to, levulinic acid, mandelic acid, glycolic acid, citric acid, lactic acid, malic acid, tartaric acid, phytic acid, hydroxycaprylic acid, hydroxycapric acid, glutaric acid, gluconic
acid, or a combination of two or more thereof. The alpha hydroxy acid and/or a salt thereof may comprise citric acid, lactic acid, glycolic acid, malic acid, tartaric acid, levulinic acid, a salt thereof, or a combination of two or more thereof. Preferably, the alpha hydroxy acid and/or a salt thereof is selected from citric acid, lactic acid, levulinic acid, a salt thereof, and a combination of two or more thereof. In some instances, the preservative system comprises lactic acid and optionally another alpha hydroxy acid and/or salt thereof, such as citric acid.
[0031] Preferably, the preservative system comprises a plurality of alpha hydroxy acids and/or salts thereof. For example, the preservative system may comprise 2, 3, 4, 5, 6, 7, or any range thereof, of alpha hydroxy acids. The home care composition may include from 2 to 5, 2 to 4, 2 or 3; from 3 to 5, 3 or 4, or 4 or 5 alpha hydroxy acids in some cases. The plurality of alpha hydroxy acids may comprise or consist of levulinic acid, mandelic acid, glycolic acid, citric acid, lactic acid, malic acid, tartaric acid, phytic acid, hydroxycaprylic acid, hydroxycapric acid, glutaric acid, gluconic acid, or a combination of two or more thereof. Preferably, two or more of the plurality of alpha hydroxy acids are selected from citric acid, lactic acid, glycolic acid, malic acid tartaric acid, levulinic acid, a salt thereof, and a combination of two or more thereof. In some embodiments, at least one of the plurality of alpha hydroxy acids comprises lactic acid and/or a salt thereof. Additionally or alternatively, at least one of the plurality of alpha hydroxy acids may be citric acid and/or a salt thereof. The plurality of alpha hydroxy acids may comprise levulinic acid and/or a salt thereof in some cases.
[0032] In some preferred embodiments, the preservative system comprises lactic acid and/or a salt thereof and citric acid and/or a salt thereof. The preservative system may comprise lactic acid and/or a salt thereof and citric acid and/or a salt thereof, wherein the amount of lactic acid and/or a salt thereof is, preferably, from about 0.01 to about 1 wt.% about 0.01 to about 0.8 wt.%, about 0.01 to about 0.6 wt.%, about 0.01 to about 0.5 wt.%, about 0.01 to about 0.4 wt.%; from about 0.05 to about 1 wt.%, about 0.05 to about 0.8 wt.%, about 0.05 to about 0.6 wt.%, about 0.05 to about 0.5 wt.%, about 0.05 to about 0.4 wt.%; from about 0.1 to about 1 wt.% about 0.1 to about 0.8 wt.%, about 0.1 to about 0.6 wt.%, about 0.1 to about 0.5 wt.%, about 0.1 to about 0.4 wt.%; from about 0.2 to about 1 wt.% about 0.2 to about 0.8 wt.%, about 0.2 to about 0.6 wt.%, about 0.2 to about 0.5 wt.%; from about 0.3 to about 1 wt.% about 0.3 to about 0.8 wt.%, about 0.3 to about 0.6 wt.%, about 0.3 to about 0.5 wt.%, including any range or subrange thereof, or any range disclosed below with reference to the amount of alpha hydroxy acid(s) and/or a salt(s), based on
the total weight of the home care composition. Additionally or alternatively, the amount of citric acid and/or a salt thereof may be from about 0.05 to about 1 wt.%, about 0.05 to about 0.8 wt.%, about 0.05 to about 0.6 wt.%, about 0.05 to about 0.5 wt.%, about 0.05 to about 0.4 wt.%; from about 0.1 to about 1 wt.% about 0.1 to about 0.8 wt.%, about 0.1 to about 0.6 wt.%, about 0.1 to about 0.5 wt.%, about 0.1 to about 0.4 wt.%; from about 0.2 to about 1 wt.% about 0.2 to about 0.8 wt.%, about 0.2 to about 0.6 wt.%, about 0.2 to about 0.5 wt.%; from about 0.3 to about 1 wt.% about 0.3 to about 0.8 wt.%, about 0.3 to about 0.6 wt.%, about 0.3 to about 0.5 wt.%, from about 0.4 to about 1 wt.% about 0.4 to about 0.8 wt.%, about 0.4 to about 0.6 wt.%; from about 0.5 to about 1 wt.% about 0.5 to about 0.8 wt.%, about 0.5 to about 0.6 wt.%, about 0.5 to about 0.5 wt.%, including any range or subrange thereof, or any range disclosed below with reference to the amount of alpha hydroxy acid(s) and/or a salt(s), based on the total weight of the home care composition.
[0033] The home care compositions may be formulated to comprise lactic acid and/or a salt thereof and citric acid and/or a salt thereof in a weight ratio from about 3:1 to about 1:5. In some embodiments, the home care compositions have a weight ratio of lactic acid and/or a salt thereof to citric acid and/or a salt thereof of from about 3:1 to about 1:5, about 3:1 to about 1:4, about 3:1 to about 1:3, about 3:1 to about 1:2, about 3: 1 to about 1:1; from about 2:1 to about 1:5, about 2:1 to about 1:4, about 2:1 to about 1:3, about 2:1 to about 1:2, about 2:1 to about 1:1; from about 1:1 to about 1:5, about 1:1 to about 1:4, about 1:1 to about 1:3, about 1:1 to about 1:2, about 1:1, or any range or subrange thereof.
[0034] The alpha hydroxy acid(s) and/or a salt(s) thereof may be present in the home care composition in an amount of from about 0.01 to about 15 wt.%, based on the total weight of the home care composition. In some embodiments, the total amount of alpha hydroxy acid(s) and/or a salt(s) thereof present in the home care composition is from about 0.01 to about 10 wt.%, about 0.01 to about 8 wt.%, about 0.01 to about 6 wt.%, about 0.01 to about 4 wt.%, about 0.01 to about 3 wt.%, about 0.01 to about 2 wt.%, about 0.01 to about 1 wt.% about 0.01 to about 0.8 wt.%, about 0.01 to about 0.6 wt.%, about 0.01 to about 0.5 wt.%, about 0.01 to about 0.4 wt.%; from about 0.05 to about 10 wt.%, about 0.05 to about 8 wt.%, about 0.05 to about 6 wt.%, about 0.05 to 4 wt.%, about 0.05 to about 3 wt.%, about 0.05 to about 2 wt.%, about 0.05 to about 1 wt.%, about 0.05 to about 0.8 wt.%, about 0.05 to about 0.6 wt.%, about 0.05 to about 0.5 wt.%, about 0.05 to about 0.4 wt.%; from about 0.1 to about 15 wt.%, about 0.1 to about 10 wt.%, about 0.1 to
about 8 wt.%, about 0.1 to about 6 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%, about 0.1 to about 1 wt.% about 0.1 to about 0.8 wt.%, about 0.1 to about 0.6 wt.%, about 0.1 to about 0.5 wt.%, about 0.1 to about 0.4 wt.%; from about 0.3 to about 15 wt.%, about 0.3 to about 10 wt.%, about 0.3 to about 8 wt.%, about 0.3 to about 6 wt.%, about 0.3 to about 4 wt.%, about 0.3 to about 3 wt.%, about 0.3 to about 2 wt.%, about 0.3 to about 1 wt.% about 0.3 to about 0.8 wt.%, about 0.3 to about 0.6 wt.%, about 0.3 to about 0.5 wt.%; from about 0.5 to about 15 wt.%, about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%, about 0.5 to about 1 wt.%, about 0.5 to about 0.8 wt.%; from about 1 to about 15 wt.%, about 1 to about 10 wt.%, about 1 to about 8 wt.%, about 1 to about 6 wt.%, about 1 to about 4 wt.%, about 1 to about 3 wt.%, about 1 to about 2 wt.%; from about 2 to about 15 wt.%, about 2 to about 10 wt.%, about 2 to about 8 wt.%, about 2 to about 6 wt.%, about 2 to about 4 wt.%, about 2 to about 3 wt.%; from about 3 to about 15 wt.%, about 3 to about 10 wt.%, about 3 to about 8 wt.%, about 3 to about 6 wt.%, about 3 to about 4 wt.%; from about 5 to about 15 wt.%, about 5 to about 10 wt.%, about 5 to about 8 wt.%; from about 7.5 to about 15 wt.%, about 7.5 to about 10 wt.%; or from about 10 to about 15 wt.%, including ranges and subranges thereof, based on the total weight of the home care composition.
[0035] One or more preservatives other than alpha hydroxy acid and/or a salt thereof may be incorporated into the home care composition. Non-limiting examples of preservatives other than alpha hydroxy acid(s) and/or salt(s) thereof that may be incorporated into the home care composition include, but are not limited to, ethylhexylglycerin, phenoxyethanol, benzyl alcohol, parabens (such as, methylparaben, ethylparaben, propylparaben, butylparaben, isobutylparaben, etc.), sodium benzoate, ethylenediamine-tetraacetic acid (EDTA), disodium EDTA, potassium sorbate, and/or grapefruit seed extract, or combinations thereof. More than one preservative may be included in the composition. Other preservatives include salicylic acid, DMDM hydantoin, formaldahyde, chlorphenism, triclosan, imidazolidinyl urea, diazolidinyl urea, sorbic acid, methylisothiazolinone, sodium dehydroacetate, dehydroacetic acid, Quaternium-15, stearalkonium chloride, zinc pyrithione, sodium metabisulfite, 2-bromo-2-nitropropane, chlorhexidine digluconate, polyaminopropyl biguanide, benzalkonium chloride, sodium sulfite, sodium salicylate, neem oil, essential oils (various), and Vitamin E (tocopherol). In one instance, the cosmetic composition has a plurality of preservatives including or chosen from disodium
EDTA, phenoxyethanol, ethylhexylglycerin, tocopheryl acetate, and/or a mixture thereof.
[0036] The one or more preservatives other than alpha hydroxy acid and/or a salt thereof may be present in an amount from about 0.01 to about 6 wt.%, about 0.01 to about 4 wt.%, about 0.01 to about 3 wt.%, about 0.01 to about 2 wt.%, about 0.01 to about 1 wt.% about 0.01 to about 0.8 wt.%, about 0.01 to about 0.6 wt.%, about 0.01 to about 0.5 wt.%, about 0.01 to about 0.4 wt.%; from about 0.05 to about 6 wt.%, about 0.05 to 4 wt.%, about 0.05 to about 3 wt.%, about 0.05 to about 2 wt.%, about 0.05 to about 1 wt.%, about 0.05 to about 0.8 wt.%, about 0.05 to about 0.6 wt.%, about 0.05 to about 0.5 wt.%, about 0.05 to about 0.4 wt.%; from about 0.1 to about 6 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%, about 0.1 to about 1 wt.% about 0.1 to about 0.8 wt.%, about 0.1 to about 0.6 wt.%, about 0.1 to about 0.5 wt.%, about 0.1 to about 0.4 wt.%; from about 0.3 to about 6 wt.%, about 0.3 to about 4 wt.%, about 0.3 to about 3 wt.%, about 0.3 to about 2 wt.%, about 0.3 to about 1 wt.% about 0.3 to about 0.8 wt.%, about 0.3 to about 0.6 wt.%, about 0.3 to about 0.5 wt.%; from about 0.5 to about 6 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%, about 0.5 to about 1 wt.%, about 0.5 to about 0.8 wt.%; from about 1 to about 6 wt.%, about 1 to about 4 wt.%, about 1 to about 3 wt.%, about 1 to about 2 wt.%; from about 2 to about 6 wt.%, about 2 to about 4 wt.%, about 2 to about 3 wt.%, including ranges and subranges thereof, based on the total weight of the home care composition.
[0037] The surfactant systems disclosed herein typically comprise two or more surfactants selected from anionic surfactants, nonionic surfactants, amphoteric surfactants, zwitterionic surfactants, and combinations of two or more thereof. For instance, the surfactant system may include two or more surfactants, with the two or more surfactants being chosen from different categories of anionic surfactants, nonionic surfactants, amphoteric surfactants, and zwitterionic surfactants. The home care composition may include from 2 to 5, 2 to 4, 2 or 3; from 3 to 5, 3 or 4, or 4 or 5 surfactants in some cases.
[0038] The home care compositions may include one or more anionic surfactant(s) in an amount of, e.g., from about 0.5 to about 20 wt.%, based on the total weight of the home care composition. In some embodiments, the amount of anionic surfactant present in the home care composition is from about 0.5 to about 20 wt.%, about 0.5 to about 15 wt.%, about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 5 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%; about 1 to about 20 wt.%, about 1 to
about 15 wt.%, about 1 to about 10 wt.%, about 1 to about 8 wt.%, about 1 to about 6 wt.%, about 1 to about 5 wt.%, about 1 to about 4 wt.%, about 1 to about 3 wt.%, about 1 to about 2 wt.%; about 1.5 to about 20 wt.%, about 1.5 to about 15 wt.%, about 1.5 to about 10 wt.%, about 1.5 to about 8 wt.%, about 1.5 to about 6 wt.%, about 1.5 to about 5 wt.%, about 1.5 to about 4 wt.%, about 1.5 to about 3 wt.%, about 1.5 to about 2 wt.%; about 2 to about 20 wt.%, about 2 to about 15 wt.%, about 2 to about 10 wt.%, about 2 to about 8 wt.%, about 2 to about 6 wt.%, about 2 to about 5 wt.%, about 2 to about 4 wt.%; about 4 to about 20 wt.%, about 4 to about 15 wt.%, about 4 to about 10 wt.%, about 4 to about 8 wt.%, about 4 to about 6 wt.%; about 6 to about 20 wt.%, about 6 to about 15 wt.%, about 6 to about 10 wt.%, about 6 to about 8 wt.%, including all ranges and subranges thereof, based on the total weight of the home care composition.
[0039] Anionic surfactants that may be useful herein include water-soluble salts of alkyl sulfates and alkyl ether sulfates having from 8 to 20 carbon atoms in the alkyl group (e.g., sodium alkyl sulfate) and the water-soluble salts of sulfonated monoglycerides of fatty acids having from 8 to 20 carbon atoms. Sodium laurel ether sulfate (SLES), sodium lauryl sulfate, and sodium coconut monoglyceride sulfonates are examples of anionic surfactants of this type. Other suitable anionic surfactants include sarcosinates, such as sodium lauroyl sarcosinate, laurates, sodium lauryl sulfoacetate, sodium lauroyl isethionate, sodium laureth carboxylate, and sodium dodecyl benzenesulfonate. In one embodiment, the anionic surfactant comprises sodium laureth sulfate, sodium lauryl ether sulfate, sodium pareth sulfate, or a combination of two or more thereof.
[0040] In one embodiment, the home care composition includes sodium lauryl ether sulfate. The sodium lauryl ether sulfate may have an average ethoxylation of about 1 to about 5 mole per mole of lauryl ether sulfate group. In some instances, the average ethoxylation of the sodium lauryl ether sulfate is about 1 to about 4, about 1 to about 3, about 1 to about 2, or about 1 mole per mole of lauryl ether sulfate group.
[0041] Mixtures of anionic surfactants can also be employed. For instance, a variety of anionic surfactants can be utilized in the home care composition including, for example, anionic surfactants having a long chain (C6-C22) alkyl group, such as long chain alkyl sulfates, long chain alkyl sulfonates, long chain alkyl phosphates, long chain alkyl ether sulfates, long chain alkyl alpha olefin sulfonates, long chain alkyl taurates, long chain alkyl isethionates, long chain alkyl glyceryl ether sulfonates, sulfosuccinates and the like. These anionic surfactants can be alkoxylated, for example, ethoxylated, although alkoxylation is not required. These surfactants are typically highly
water soluble as their sodium, potassium, alkyl and ammonium or alkanol ammonium containing salt form and can provide high foaming cleansing power. Other equivalent anionic surfactants may be used in some cases.
[0042] The home care compositions may include one or more nonionic surfactant(s) in an amount that typically ranges from about 0.1 to about 10 wt.%, based on the total weight of the home care composition. For instance, the home care composition may include one or more nonionic surfactant(s) in an amount of from about 0.1 to about 10 wt.%, about 0.1 to about 8 wt.%, 0.1 to about 6 wt.%, about 0.1 to about 5 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%, about 0.1 to about 1 wt.%; about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 5 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%, about 0.5 to about 1 wt.%; about 0.75 to about 10 wt.%, about 0.75 to about 8 wt.%, about 0.75 to about 6 wt.%, about 0.75 to about 5 wt.%, about 0.75 to about 4 wt.%, about 0.75 to about 3 wt.%, about 0.75 to about 2 wt.%, about 0.75 to about 1 wt.%; about 1 to about 10 wt.%, about 1 to about 8 wt.%, about 1 to about 6 wt.%, about 1 to about 5 wt.%, about 1 to about 4 wt.%, about 1 to about 3 wt.%, about 1 to about 2 wt.%; about 2 to about 10 wt.%, about 2 to about 8 wt.%, about 2 to about 6 wt.%, about 2 to about 5 wt.%, about 2 to about 4 wt.%; about 4 to about 10 wt.%, about 4 to about 8 wt.%, about 4 to about 6 wt.%; about 6 to about 10 wt.%, or about 6 to about 8 wt.%, including ranges and subranges thereof, based on the total weight of the home care composition.
[0043] The nonionic surfactant may be selected from an alkanolamide, a glucoside, a fatty amine, a polyether, and a combination of two more thereof. For instance, the home care composition may include a glucoside selected from arachidyl glucoside, C12-20 alkyl glucoside, caprylyl/capryl glucoside, cetearyl glucoside, coco-glucoside, lauryl glucoside, decyl glucoside, or a combination of two more thereof. In some instances, the nonionic surfactant is selected from decyl glucoside, PEG- 120 methyl glucose dioleate, coco monoethanolamide, brassica amido propyl dimethyl amine, and a combination of two more thereof. In further instances, the nonionic surfactant comprises two or more of decyl glucoside, PEG- 120 methyl glucose dioleate, coco monoethanolamide, and/or brassica amido propyl dimethyl amine.
[0044] Examples of nonionic surfactants that may, in some cases, be suitably incorporated into the home care composition include alkylphenols and esters of fatty acids, optionally being ethoxylated, propoxylated, or glycerolated and having at least one fatty chain comprising, e.g.,
from 8 to 18 carbon atoms, it being possible for the number of ethylene oxide or propylene oxide groups to range from 2 to 50, and for the number of glycerol groups to range from 1 to 30. Maltose derivatives are also worth mentioning. Additional examples of nonionic surfactants include those made of copolymers of ethylene oxide and/or of propylene oxide; condensates of ethylene oxide and/or of propylene oxide with fatty alcohols; polyethoxylated fatty amides comprising, e.g., from 2 to 30 mole of ethylene oxide; polyglycerolated fatty amides comprising, e.g., from 1.5 to 5 glycerol groups, such as from 1.5 to 4; ethoxylated fatty acid esters of sorbitan comprising from 2 to 30 mole of ethylene oxide; ethoxylated oils from plant origin; fatty acid esters of sucrose; fatty acid esters of polyethylene glycol; N-(C6-C24)alkylglucamine derivatives, amine oxides such as (Cio-C 14) alkylamine oxides or N-(Cio-Ci4)acylaminopropylmorpholine oxides; and a combination of two or more thereof.
[0045] The nonionic surfactants may, additionally or alternatively, be chosen from those broadly defined as compounds produced by the condensation of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic compound which may be aliphatic or alkyl-aromatic in nature. Other examples of suitable nonionic surfactants include but are not limited to monoethanol amides, for example, alkyl monoethanolamides, such as cocomonoethanolamide, lauramide monoethanolamide, and the like. Further examples of nonionic surfactants include poloxamers, polyoxyethylene, polyoxyethylene sorbitan esters, hydrogenated castor oil, fatty alcohol ethoxylates, polyethylene oxide condensates of alkyl phenols, products derived from the condensation of ethylene oxide with the reaction product of propylene oxide and ethylene diamine, ethylene oxide condensates of aliphatic alcohols, alkyl polyglycosides (e.g., fatty alcohol ethers of polyglycosides, such as fatty alcohol ethers of polyglucosides having decyl, lauryl, capryl, caprylyl, myristyl, stearyl groups; other ethers of glucose; and polyglucoside polymers, including mixed ethers such as capryl /caprylyl glucoside, coco glucoside, and lauryl glucoside), long chain tertiary amine oxides, long chain tertiary phosphine oxides, long chain dialkyl sulfoxides, and mixtures of two or more thereof.
[0046] Additional examples of nonionic surfactants include polysorbate 20, long chain alkyl glucosides having C8-C22 alkyl groups; coconut fatty acid monoethanolamides, such as cocamide MEA; coconut fatty acid diethanolamides; fatty alcohol ethoxylates (alkylpolyethylene glycols); alkylphenol polyethylene glycols; alkyl mercaptan polyethylene glycols; fatty amine ethoxylates (alkylaminopolyethylene glycols); fatty acid ethoxylates (acylpolyethylene glycols);
polypropylene glycol ethoxylates; fatty acid alkylolamides, (fatty acid amide polyethylene glycols); N-alkyl-, N-alkoxypolyhydroxy fatty acid amides; sucrose esters; sorbitol esters; polyglycol ethers; and combinations of two or more thereof.
[0047] The home care compositions may include one or more amphoteric surfactant(s). The amount of amphoteric surfactants present in the home care composition may be from about 0.1 to about 10 wt.%, based on the total weight of the home care composition. For example, the home care composition may include one or more amphoteric surfactant(s) in an amount of from about 0.1 to about 10 wt.%, about 0.1 to about 8 wt.%, 0.1 to about 6 wt.%, about 0.1 to about 5 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%, about 0.1 to about 1 wt.%; about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 5 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%, about 0.5 to about 1 wt.%; about 0.75 to about 10 wt.%, about 0.75 to about 8 wt.%, about 0.75 to about 6 wt.%, about 0.75 to about 5 wt.%, about 0.75 to about 4 wt.%, about 0.75 to about 3 wt.%, about 0.75 to about 2 wt.%, about 0.75 to about 1 wt.%; about 1 to about 10 wt.%, about 1 to about 8 wt.%, about 1 to about 6 wt.%, about 1 to about 5 wt.%, about 1 to about 4 wt.%, about 1 to about 3 wt.%, about 1 to about 2 wt.%; about 2 to about 10 wt.%, about 2 to about 8 wt.%, about 2 to about 6 wt.%, about 2 to about 5 wt.%, about 2 to about 4 wt.%; about 4 to about 10 wt.%, about 4 to about 8 wt.%, about 4 to about 6 wt.%; about 6 to about 10 wt.%, or about 6 to about 8 wt.%, including ranges and subranges thereof, based on the total weight of the home care composition.
[0048] Amphoteric surfactants are typically characterized by a combination of high surfactant activity, lather forming and mildness. The amphoteric surfactant may comprise a substituent containing 8 to 18 carbon atoms and a substituent containing one or more carboxylate, sulfonate, sulfate, phosphate, or phosphonate. The amphoteric surfactant(s) may include, but are not limited to, derivatives of aliphatic secondary and tertiary amines in which the aliphatic radical can be straight chain or branched and wherein one of the aliphatic substituents contains about 8 to about 18 carbon atoms and one contains an anionic water solubilizing group, e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate. Examples of such compounds include sodium 3- dodecyaminopropionate, sodium 3-dodecylaminopropane sulfonate, N-alkyl taurines and N- higher alkyl aspartic acids. Other equivalent amphoteric surfactants may be used in some cases. [0049] Additional examples of amphoteric surfactants include, but are not limited to, a range of
betaines including, e.g., high alkyl betaines, such as coco dimethyl carboxymethyl betaine, lauryl dimethyl carboxy-methyl betaine, lauryl dimethyl alpha-carboxycthyl betaine, cetyl dimethyl carboxymethyl betaine, lauryl bis-(2-hydroxyethyl)carboxy methyl betaine, stearyl bis-(2- hydroxypropyl)carboxymethyl betaine, oleyl dimethyl gamma-carboxypropyl betaine, and lauryl bis-(2-hydroxypropyl)alpha-carboxyethyl betaine, sulfobetaines (such as coco dimethyl sulfopropyl betaine), stearyl dimethyl sulfopropyl betaine, amido betaines, amidosulfobetaines and the like. Betaines having a long chain alkyl group, particularly coco, may be useful as are those that include an amido group, such as the cocamidopropyl and cocoamidoethyl betaines. In at least one embodiment, the betaine surfactant is selected from cocamidopropyl betaine, lauryl dimethyl betaine, cetyl dimethyl betaine, and cocoamphodiacetate, and a combination of two or more thereof.
[0050] Mixtures of amphoteric surfactants can also be employed. Further examples of suitable amphoteric surfactants include sultaines, also known as sulfobetaines, and hydroxy sultaines, such as cocamidopropyl hydroxy sul tain. Additional amphoteric surfactants and nonionic surfactants can be found in U.S. Pat. No. 4,051,234, which is incorporated herein in its entirety for all purposes.
[0051] Cationic surfactants can, optionally, be included in the home care composition. The cationic surfactant, when present, is typically included in the home care composition in an amount of from about 0.1 to about 10 wt.%, about 0.1 to about 8 wt.%, 0.1 to about 6 wt.%, about 0.1 to about 5 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%, about 0.1 to about 1 wt.%; from about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 5 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%, about 0.5 to about 1 wt.%; from about 0.75 to about 10 wt.%, about 0.75 to about 8 wt.%, about 0.75 to about 6 wt.%, about 0.75 to about 5 wt.%, about 0.75 to about 4 wt.%, about 0.75 to about 3 wt.%, about 0.75 to about 2 wt.%, about 0.75 to about 1 wt.%; from about 1 to about 10 wt.%, about 1 to about 8 wt.%, about 1 to about 6 wt.%, about 1 to about 5 wt.%, about 1 to about 4 wt.%, about 1 to about 3 wt.%, about 1 to about 2 wt.%; about 2 to about 10 wt.%, about 2 to about 8 wt.%, about 2 to about 6 wt.%, about 2 to about 5 wt.%, about 2 to about 4 wt.%; from about 4 to about 10 wt.%, about 4 to about 8 wt.%, about 4 to about 6 wt.%; from about 6 to about 10 wt.%, or about 6 to about 8 wt.%, including ranges and subranges thereof, based on the total weight of the home care composition.
[0052] The term “cationic surfactant” means a surfactant that may be positively charged when it is contained in the home care compositions according to the disclosure. This surfactant may bear one or more positive permanent charges or may contain one or more functional groups that are cationizable in the home care composition according to the disclosure.
[0053] The one or more cationic surfactants, if present, may include or be chosen from quaternary ammonium compounds, amidoamines, or a mixture of two or more thereof. Examples of cationic surfactants that may be suitable for the home care composition may be chosen from cetrimonium chloride, steartrimonium chloride, behentrimonium chloride, behentrimonium methosulfate, behenamidopropyltrimonium methosulfate, stearamidopropyltrimonium chloride, arachidtrimonium chloride, distearyldimonium chloride, dicetyldimonium chloride, tricetylmonium chloride, oleamidopropyl dimethylamine, linoleamidopropyl dimethylamine, isostearamidopropyl dimethylamine, oleyl hydroxyethyl imidazoline, stearamidopropyldimethylamine, behenamidopropyldimethylamine, behenamidopropyldiethylamine, behenamidoethyldiethyl-amine, behenamidoethyldimethylamine, arachidamidopropyldimethylamine, arachidamido- propyidiethylamine, arachidamidoethyidiethylamine, arachidamidoethyidimethylamine, and a combination of two or more thereof.
[0054] Additional, non-limiting examples of cationic surfactants include: cetyl trimethyl ammonium chloride available, stearyl trimethyl ammonium chloride, hydrogenated tallow alkyl trimethyl ammonium chloride, stearyl dimethyl benzyl ammonium chloride, stearyl propyleneglycol phosphate dimethyl ammonium chloride, stearoyl amidopropyl dimethyl benzyl ammonium chloride, stearoyl amidopropyl dimethyl (myristylacetate) ammonium chloride, and N-(stearoyl colamino formyl methy) pyridinium chloride.
[0055] Hydrophilically substituted cationic surfactants in which at least one of the substituents contain one or more aromatic, ether, ester, amido, or amino moieties present as substituents or as linkages in the chain may also be in the home care composition. Non-limiting examples of hydrophilically substituted cationic surfactants that may be useful in the home care compositions include the materials having the following INCI designations: quaternium-16, quatemium-26, quatemium-27, quaternium-30, quaternium-33, quatemium-43, quaternium-52, quaternium-53, quatemium-56, quaternium-60, quaternium-61, quatemium-62, quaternium-70, quaternium-71, quatemium-72, quaternium-75, quaternium-76 hydrolyzed collagen, quaternium-77, quatemium-
78, quatemium-79 hydrolyzed collagen, quaternium-79 hydrolyzed keratin, quatemium-79 hydrolyzed milk protein, quatcrnium-79 hydrolyzed silk, quatcrnium-79 hydrolyzed soy protein, and quaternium-79 hydrolyzed wheat protein, quaternium-80, quaternium-81, quatemium-82, quatemium-83, quaternium-84, or a combination of two or more thereof.
[0056] In certain instances, the cationic surfactant is selected from cetrimonium chloride, stearimonium chloride, behentrimonium chloride, behentrimonium methosulfate, behenamidopropyltrimonium methosulfate, stearamidopropyltrimonium chloride, arachidtrimonium chloride, distearyldimonium chloride, dicetyldimonium chloride, tricetylmonium chloride, oleamidopropyl dimethylamine, linoleamidopropyl dimethylamine, isostearamidopropyl dimethylamine, oleyl hydroxyethyl imidazoline, stearamidopropyldimethylamine, behenamidopropyldimethylamine, behenamidopropyldiethylamine, behenamidoethyldiethyl- amine, behenamidoethyldimethylamine, arachidamidopropyldimethylamine, arachidamido- propyidiethylamine, arachidamidoethyidiethylamine, arachidamidoethyidimethylamine, and a combination of two or more thereof. In some cases, the cationic surfactant is selected from cetrimonium chloride, behentrimonium chloride, and a combination of two or more thereof.
[0057] In some cases, the home care compositions may include one or more base(s). The one or more base(s), if present in the home care compositions, are typically in an amount of from about 0.01 to about 5 wt.%, based on the total weight of the home care composition. For example, the home care composition may include one or more base(s) in amount of from about 0.01 to about 3 wt.%, 0.01 to about 2 wt.%, about 0.01 to about 1.5 wt.%, about 0.01 to about 1 wt.%, about 0.01 to about 0.5 wt.%; from about 0.05 to about 5 wt.%, about 0.05 to about 3 wt.%, about 0.05 to about 2 wt.%, about 0.05 to about 1.5 wt.%, about 0.05 to about 1 wt.%, about 0.05 to about 0.5 wt.%; from about 0.1 to about 5 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%, about 0.1 to about 1.5 wt.%, about 0.1 to about 1 wt.%, about 0.1 to about 0.5 wt.%; from about 0.5 to about 5 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%, about 0.5 to about 1.5 wt.%, about 0.5 to about 1 wt.%; from about 0.75 to about 5 wt.%, about 0.75 to about 3 wt.%, about 0.75 to about 2 wt.%, about 0.75 to about 1.5 wt.%, about 0.75 to about 1 wt.%; from about 1 to about 5 wt.%, about 1 to about 3 wt.%, about 1 to about 2 wt.%; from about 2 to about 5 wt.%, about 2 to about 4 wt.%, or about 2 to about 3 wt.%, including ranges and subranges thereof, based on the total weight of the home care composition.
[0058] The one or more base(s) comprise or be selected from caustic soda, sodium hydroxide, triethanolamine, and a combination thereof. Other examples of bases include potassium hydroxide, lye, metal hydroxide, metal hydroxide, and the like. In at least one embodiment, the home care composition comprises caustic soda.
[0059] The home care compositions may comprise one or more fatty acid(s) and/or neutralized derivatives thereof. The amount of fatty acid and/or neutralized derivatives thereof present in the home care composition may be from about 0.1 to about 30 wt.%, based on the total weight of the home care composition. In some embodiments, the amount of fatty acid and/or neutralized derivatives thereof present in the home care composition is from about 0.1 to about 30 wt.%, about 0.1 to about 25 wt.%, about 0.1 to about 20 wt.%, about 0.1 to about 15 wt.%, about 0.1 to about 10 wt.%, about 0.1 to about 8 wt.%, about 0.1 to about 6 wt.%, about 0.1 to about 5 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%; from about 0.5 to about 30 wt.%, about 0.5 to about 25 wt.%, about 0.5 to about 20 wt.%, about 0.5 to about 15 wt.%, about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 5 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%; from about 1 to about 30 wt.%, about 1 to about 25 wt.%, about 1 to about 20 wt.%, about 1 to about 15 wt.%, about 1 to about 10 wt.%, about 1 to about 8 wt.%, about 1 to about 6 wt.%, about
1 to about 5 wt.%, about 1 to about 4 wt.%, about 1 to about 3 wt.%, about 1 to about 2 wt.%; from about 1.5 to about 30 wt.%, about 1.5 to about 25 wt.%, about 1.5 to about 20 wt.%, about 1.5 to about 15 wt.%, about 1.5 to about 10 wt.%, about 1.5 to about 8 wt.%, about 1.5 to about 6 wt.%, about 1.5 to about 5 wt.%, about 1.5 to about 4 wt.%, about 1.5 to about 3 wt.%, about 1.5 to about
2 wt.%; from about 2 to about 30 wt.%, about 2 to about 25 wt.%, about 2 to about 20 wt.%, about 2 to about 15 wt.%, about 2 to about 10 wt.%, about 2 to about 8 wt.%, about 2 to about 6 wt.%, about 2 to about 5 wt.%, about 2 to about 4 wt.%; from about 4 to about 30 wt.%, about 4 to about 25 wt.%, about 4 to about 20 wt.%, about 4 to about 15 wt.%, about 4 to about 10 wt.%, about 4 to about 8 wt.%, about 4 to about 6 wt.%; from about 6 to about 30 wt.%, about 6 to about 25 wt.%, about 6 to about 20 wt.%, about 6 to about 15 wt.%, about 6 to about 10 wt.%, about 6 to about 8 wt.%, including all ranges and subranges thereof, based on the total weight of the home care composition
[0060] The one or more fatty acids may, in some cases, may comprise myristic acid, lauric acid, palmitic acid, stearic acids, and/or other fatty acids. Sources of fatty acids include coconut oil,
palm oil, palm kernel oil, tallow, avocado, canola, corn, cottonseed, olive, hi-oleic sunflower, mid- olcic sunflower, sunflower, palm stearin, palm kernel olein, safflower, babassu oils, and mixtures thereof.
[0061] The fatty acids can be neutralized with a neutralizing agent, such as base, including those described herein. Typical bases include, but are not limited to, sodium hydroxide, potassium hydroxide, and triethanolamine. In certain embodiments, the home care composition is formed from fatty acids neutralized by two or more bases. In certain embodiments, the bases are sodium hydroxide and triethanolamine. In certain embodiments, the molar ratio of sodium hydroxide and triethanolamine is from about 4:1 to about 1:4, about 3:1 to about 1:3, or about 2:1 to about 1:2. In at least one embodiment, the home care composition has a molar ratio of sodium hydroxide to triethanolamine of about 1:1.
[0062] Additionally or alternatively, the home care composition may include a fatty acid comprising stearic acid and an acid comprising lauric acid. In certain embodiments, the amount of stearic acid based on a total weight of starting fatty acids is 60 wt.%, and the amount of lauric acid based on a total weight of starting fatty acids is 40 wt.%. In certain embodiments, the molar amount of fatty acids is greater than the molar amount of neutralizing agent such that fatty acid remains in the composition.
[0063] The fatty acid may be neutralized with neutralizing agents selected from alkali metal carbonates, alkali metal phosphates, organic amines, hydroxide base compounds, and mixtures thereof, and particularly from, e.g., organic amines, alkali metal hydroxides, alkali earth metal hydroxides, and mixtures thereof. Organic amines may be selected from amino-2-methyl-l- propanol (or aminomethyl propanol), ethylamines, ethyleneamines, alkanolamines, cyclic amines and other cyclic compounds, saturated or unsaturated, having one or more nitrogen atoms within the ring, and mixtures thereof. The organic amines may be chosen from the ones having a pKb at a temperature of 25°C of less than 12, such as less than 10 or less than 6. It should be noted that this is the pKb corresponding to the function of highest basicity.
[0064] Non-limiting examples of organic amines include organic amines comprising one or two primary, secondary, or tertiary amine functions, and at least one linear or branched Ci-Cs alkyl groups bearing at least one hydroxyl radical. Organic amines may also be chosen from alkanolamines, such as mono-, di- or trialkanolamines, comprising one to three identical or different C1-C4 hydroxyalkyl radicals, ethylamines, ethyleneamines, quinoline, aniline and cyclic
amines, such as pyrroline, pyrrole, pyrrolidine, imidazole, imidazolidine, imidazolidinine, morpholine, pyridine, piperidine, pyrimidine, piperazine, triazinc and derivatives thereof. Examples of compounds of the alkanolamine type include, but are not limited to, monoethanolamine (also known as monoethanolamine or MEA), diethanolamine, triethanolamine, monoisopropanolamine, diisopropanolamine, N-dimethylaminoethanolamine, 2- amino-2-methyl-l -propanol, triisopropanolamine, 2-amino-2-methyl-l,3-propanediol, 3-amino- 1 ,2-propanediol, 3-dimethylamino-l,2-propanediol, 2-amino-2-methyl- 1 -propanol, and tris(hydroxymethylamino)methane. Other examples include, but are not limited to: 1,3- diaminopropane, l,3-diamino-2-propanol, spermine, and spermidine.
[0065] In some cases, the home care composition may include a thickening agent. The thickening agent may be included in the home care compositions in an amount from about 0.1 to about 20 wt.%, based on the total weight of the home care composition. For example, the thickening agent may be present in the home care composition in an amount of from about 0.1 to about 15 wt.%, about 0.1 to about 10 wt.%, about 0.1 to about 8 wt.%, about 0.1 to about 6 wt.%, about 0.1 to about 5 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%; from about 1 to 20 wt.%, about 1 to about 15 wt.%, about 1 to about 10 wt.%, about 1 to about 8 wt.%, about 1 to about 6 wt.%, about 1 to about 5 wt.%, about 1 to about 4 wt.%, about 1 to about 3 wt.%, about 1 to about 2 wt.%; from about 2 to about 20 wt.%, about 2 to about 15 wt.%, about 2 to about 10 wt.%, about 2 to about 8 wt.%, about 2 to about 6 wt.%, about 2 to about 5 wt.%, about 2 to about 4 wt.%; from about 4 to about 20 wt.%, about 4 to about 15 wt.%, about 4 to about 10 wt.%, about 4 to about 8 wt.%, about 4 to about 6 wt.%; from about 6 to about 20 wt.%, about 6 to about 15 wt.%, about 6 to about 10 wt.%, about 6 to about 8 wt.%; from about 8 to about 20 wt.%, about 8 to about 15 wt.%, about 8 to about 10 wt.%; from about 10 to about 20 wt.%, or about 10 to about 15 wt.%, including ranges and subranges thereof, based on the total weight of the home care composition.
[0066] Typically, thickening agent can increase the viscosity or yield point in the home care composition. Examples of the thickening agents include, but are not limited to, clay, polymers, polymeric gums, polysaccharides, microfibrous cellulose, gellan gum, pectine, alginate, arabinogalactan, carageenan, xanthan gum, guar gum, rhamsan gum, furcellaran gum, and other natural gums.
[0067] A polymer thickening agent in one embodiment is a polyacrylate. Examples of
polyacrylates include acrylates/steareth-20 methacrylate crosspolymer, acrylates/steareth-20 methacrylate crosspolymcr, and combinations thereof. Non-limiting examples, of polymers that may be included as thickening agents, solely or in conjunction with other thickening agents, include polyvinyl pyrrolidone, carbomers (e.g., carboxyvinyl polymers), carrageenans (e.g., Irish moss, carrageenan, iota-carrageenan, etc.), high molecular weight polyethylene glycols, cellulosic polymers, hydroxyethylcellulose, carboxymethylcellulose, and salts thereof (e.g., CMC sodium), natural gums (e.g., karaya, xanthan, gum arabic, and tragacanth), colloidal magnesium aluminum silicate, and the like, and mixtures or combinations of two or more thereof. The thickening agent may, optionally, comprise gums, sucrose esters, polyvinylpyrrolidone (PVP) and co-polymers, celluloses, polyquaternium compounds, and carboxylic acid or carboxylate based homopolymer or co-polymer, which can be linear or crosslinked.
[0068] The home care compositions may, in some embodiments, include one or more polyol(s). The one or more polyol(s) may be present in the home care composition in an amount from about 0.1 to about 20 wt.%, based on the total weight of the home care composition. In some instances, the home care compositions include one or more polyol(s) in an amount from about 0.1 to about 18 wt.%, about 0.1 to about 16 wt.%, about 0.1 to about 14 wt.%, about 0.1 to about 12 wt.%, about 0.1 to about 10 wt.%, about 0.1 to about 8 wt.%, about 0.1 to about 6 wt.%, about 0.1 to about 4 wt.%; from about 0.5 to about 20 wt.%, about 0.5 to about 18 wt.%, about 0.5 to about 16 wt.%, about 0.5 to about 14 wt.%, about 0.5 to about 12 wt.%, about 0.5 to about 10 wt.%, about 0.5 to about 8 wt.%, about 0.5 to about 6 wt.%, about 0.5 to about 4 wt.%; from about 1 to about 20 wt.%, about 1 to about 18 wt.%, about 1 to about 16 wt.%, about 1 to about 14 wt.%, about 1 to about 12 wt.%, about 1 to about 10 wt.%, about 1 to about 8 wt.%, about 1 to about 6 wt.%, about 1 to about 4 wt.%; from about 2 to about 20 wt.%, about 2 to about 18 wt.%, about 2 to about 16 wt.%, about 2 to about 14 wt.%, about 2 to about 12 wt.%, about 2 to about 10 wt.%, about 2 to about 8 wt.%, about 2 to about 6 wt.%, about 2 to about 4 wt.%; from about 4 to about 20 wt.%, about 4 to about 18 wt.%, about 4 to about 16 wt.%, about 4 to about 14 wt.%, about 4 to about 12 wt.%, about 4 to about 10 wt.%, about 4 to about 8 wt.%, or about 4 to about 6 wt.%, including ranges and subranges thereof, based on the total weight of the home care composition.
[0069] The term "polyol" should be understood as meaning, within the meaning of the present disclosure, an organic molecule comprising at least two free hydroxyl groups. The polyols of the home care composition may be glycols or compounds with numerous hydroxyl groups. In some
cases, the polyol(s) is selected from the group consisting of C2-C32 polyols. The one or more polyols may be liquid at ambient temperature (25 °C). The polyol(s) may have from 2 to 32 carbon atoms, from 3 to 16 carbon atoms, or from 3 to 12 carbon atoms.
[0070] Polyols that may be included in the home care composition, in certain instances, include ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, glycerin, diglycerin, diethylene glycol, dipropylene glycol, and combinations of two or more thereof. In some cases, the polyol is propylene glycol. In some further cases, the polyol is one or both of propylene glycol and butylene glycol. Non-limiting examples of polyols that may, optionally, be included in the home care include those chosen from alkanediols, such as glycerin, 1,2,6-hexanetriol, trimethylolpropane, ethylene glycol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, pentaethylene glycol, dipropylene glycol, 2-butene- 1 ,4-diol, 2-ethyl- 1 ,3-hexanediol, 2-methyl-2,4-pentanediol, caprylyl glycol, 1 ,2-hexanediol, 1,2-pentanediol, and 4-methyl-l,2-pentanediol; glycol ethers, such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, ethylene glycol monomethyl ether acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol mono-n-propyl ether, ethylene glycol mono-iso-propyl ether, diethylene glycol mono-iso-propyl ether, ethylene glycol mono-n-butyl ether, ethylene glycol mono-t-butyl ether, diethylene glycol mono-t-butyl ether, 1 -methyl- 1 -methoxybutanol, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol mono-t- butyl ether, propylene glycol mono-n-propyl ether, propylene glycol mono-iso-propyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol mono-n-propyl ether, dipropylene glycol mono-iso-propyl ether; sorbitol; sorbitan; triacetin; and a combination of two or more thereof.
[0071] The one or more polyols may, optionally, be glycols or glycol ethers such as, e.g., monomethyl, monoethyl and monobutyl ethers of ethylene glycol, propylene glycol or ethers thereof, such as, monomethyl ether of propylene glycol, butylene glycol, hexylene glycol, dipropylene glycol as well as alkyl ethers of diethylene glycol, such as monoethyl ether or monobutyl ether of diethylene glycol. In some cases, the one or more polyols may include or are chosen from ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, pentylene glycol, 1,3-propanediol, diethylene glycol, dipropylene glycol, 1,4-butanediol, 1,5-pentanediol, hexane- 1 ,6-diol, glycerin, diglycerin, caprylyl glycol, and a mixture of two or more thereof.
[0072] The home care compositions may be aqueous and, e.g., include water in an amount from about 1 to about 95 wt.%, based on the total weight of the home care composition. For example, the water may be present in the home care composition in an amount from about 5 to about 95 wt.%, about 10 to about 95 wt.%, about 15 to about 95 wt.%, about 20 to about 95 wt.%, about 30 to about 95 wt.%, about 40 to about 95 wt.%, about 50 to about 95 wt.%, about 60 to about 95 wt.%, about 70 to about 95 wt.%, about 80 to about 95 wt.%, about 90 to about 95 wt.%; from about 5 to about 90 wt.%, about 10 to about 90 wt.%, about 15 to about 90 wt.%, about 20 to about 90 wt.%, about 30 to about 90 wt.%, about 40 to about 90 wt.%, about 50 to about 90 wt.%, about 60 to about 90 wt.%, about 70 to about 90 wt.%, about 80 to about 90 wt.%; from about 5 to about 80 wt.%, about 10 to about 80 wt.%, about 15 to about 80 wt.%, about 20 to about 80 wt.%, about 30 to about 80 wt.%, about 40 to about 80 wt.%, about 50 to about 80 wt.%, about 60 to about 80 wt.%, about 70 to about 80 wt.%; from about 5 to about 70 wt.%, about 10 to about 70 wt.%, about 15 to about 70 wt.%, about 20 to about 70 wt.%, about 30 to about 70 wt.%, about 40 to about 70 wt.%, about 50 to about 70 wt.%, about 60 to about 70 wt.%; from about 5 to about 60 wt.%, about 10 to about 60 wt.%, about 15 to about 60 wt.%, about 20 to about 60 wt.%, about 30 to about 60 wt.%, about 40 to about 60 wt.%, about 50 to about 60 wt.%; from about 5 to about 50 wt.%, about 10 to about 50 wt.%, about 15 to about 50 wt.%, about 20 to about 50 wt.%, about 30 to about 50 wt.%, or about 40 to about 50 wt.%, including any ranges and subranges therebetween, based on the total weight of the home care composition.
[0073] Additional ingredients may be present in the home care composition. The additional ingredients may include, e.g., ingredients to preserve, emulsify, add fragrance, stabilize (e.g., chelating agents), adjust the pH, and color. The home care compositions may include any of the following additional ingredients in an amount of from about 0.01 to about 5 wt.%, based on the total weight of the home care composition. In some instances, the amount of additional ingredients present in the home care composition is from about 0.01 to about 4 wt.%, about 0.01 to about 3 wt.%, about 0.01 to about 2 wt.%, about 0.01 to about 1 wt.%, about 0.01 to about 0.5 wt.%, about 0.01 to about 0.1 wt.%; from about 0.1 to about 5 wt.%, about 0.1 to about 4 wt.%, about 0.1 to about 3 wt.%, about 0.1 to about 2 wt.%, about 0.1 to about 1 wt.%, about 0.1 to about 0.5 wt.%, about 0.1 to about 0.1 wt.%; from about 0.5 to about 5 wt.%, about 0.5 to about 4 wt.%, about 0.5 to about 3 wt.%, about 0.5 to about 2 wt.%, about 0.5 to about 1 wt.%; from about 0.75 to about 5 wt.%, about 0.75 to about 4 wt.%, about 0.75 to about 3 wt.%, about 0.75 to about 2 wt.%, about
0.75 to about 1 wt.%; from about 1 to about 5 wt.%, about 1 to about 4 wt.%, about 1 to about 3 wt.%, about 1 to about 2 wt.%; from about 2 to about 5 wt.%, about 2 to about 4 wt.%, about 2 to about 3 wt.%; from about 3 to about 5 wt.%, about 3 to about 4 wt.%, including any range or subrange therebetween, based on the total weight of the home care composition.
[0074] Non-limiting examples of fragrances and perfumes include odor compounds selected from: 7-acetyl-l,2,3,4,5,6,7,8-octahydro-l,l,6,7-tetramethylnaphthalene, a-ionone, P-ionone, y- ionone a-isomcthy I ionone, methylcedrylone, methyl dihydrojasmonate, methyl 1,6,10-trimethyl- 2,5,9-cyclododecatrien-l-yl ketone, 7-acetyl-l,l,3,4,4,6-hexamethyltetralin, 4-acetyl-6-tert- buty 1-1,1 -dimethylindane, hydroxyphenylbutanone, benzophenone, methyl P-naphthyl ketone, 6- acetyl- 1 , 1 ,2,3,3,5-hexamethylindane, 5-acetyl-3-isopropyl- 1 , 1 ,2,6-tetramethylindane, 1- dodecanal, 4-(4-hydroxy-4-methylpentyl)-3-cyclohexene-l-carboxaldehyde, 7 -hydroxy-3, 7- dimethyloctanal, 10-undecen-l-al, isohexenylcyclohexylcarboxaldehyde, formyltricyclodecane, condensation products of hydroxycitronellal and methyl anthranilate, condensation products of hydroxycitronellal and indole, condensation products of phenylacetaldehyde and indole, 2- methyl-3-(para-tert-butylphenyl)propionaldehyde, ethylvanillin, heliotropin, hexylcinnamaldehyde, amylcinnamaldehyde, 2-methyl-2-(isopropylphenyl)propionaldehyde, coumarin, y-decalactone, cyclopentadecanolide, 16-hydroxy-9-hexadecenoic acid lactone, l,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylcyclopenta-y-2-benzopyran, P-naphthol methyl ether, ambroxane, dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,lb]furan, cedrol, 5-(2,2,3- trimethylcyclopent-3-enyl)-3-methylpentan-2-ol, 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-l-yl)- 2-buten-l-ol, caryophyllene alcohol, tricyclodecenyl propionate, tricyclodecenyl acetate, benzyl salicylate, cedryl acetate, tert-butylcyclohexyl acetate, and combinations of two or more thereof. [0075] Other fragrances may include odor compounds selected from essential oils, resinoids and resins from a large number of sources, such as Peru balsam, olibanum resinoid, styrax, labdanum resin, nutmeg, cassia oil, benzoin resin, coriander, and lavandin.
[0076] Further suitable fragrances include odor compounds selected from phenylethyl alcohol, terpineol, linalool, linalyl acetate, geraniol, nerol, 2-(l,l-dimethylethyl)cyclo-hexanol acetate, benzyl acetate, eugenol, and a combination of two or more thereof. The fragrances or perfumes can be used as single substances or in a mixture with one another.
[0077] The home care composition may further comprise one or more colorants. The colorants may be a pigment, a dye, or mixtures thereof. Non-limiting examples of pigments include titanium
dioxide, zinc oxide, kaolin, mica, etc. Non-limiting examples of dyes include food dyes suitable for food, drug and cosmetic applications, and mixtures thereof. Some color agents (colorants) arc known as FD&C dyes.
[0078] The colorants may be present in an amount ranging from about 0.0001 wt.% to about 0.4 wt.%, including all percentages and subranges therebetween, based on the total weight of the home care composition. In some embodiments, the colorants may be present in an amount ranging from about 0.0001 wt.% to about 4 wt.%, including all percentages and subranges therebetween, based on the total weight of the home care composition.
[0079] Non-limiting examples of chemical chelating agents include aminotrimethyl phosphonic acid, B-alanine diacetic acid, cyclodextrin, cyclohexanediamine tetracetic acid, diethylenetriamine pentamethylene phosphonic acid, diethanolamine N-acetic acid, ethylene diamine tetracetic acid (EDTA or YH4) and its sodium (YH3Na, Y2H2Na2, YHNa3 and YNa4), potassium (YH3K, Y2H3K3 and YK4), calcium disodium, and diammonium salts and its salts with triethanolamine (TEA- EDTA), etidronic acid, galactanic acid, hydroxyethyl ethylenediamine tetracetic acid (HEDTA) and its trisodium salt, gluconic acid, glucuronic acid, nitrilotriacetic acid (NT A) and its trisodium salt, pentetic acid, phytic acid, ribonic acid, diammonium citrate, disodium azacycloheptane diphosphonate, disodium pyrophoshate, hydroxypropyl cyclodextrin, methyl cyclodextrin, pentapotassium triphosphate, pentasodium aminotrimethylene phosphonate, pentasodium ethylenediamine tetramethylene phosphonate, pentasodium pentetate, pentasodium triphosphate, potassium citrate, potassium EDTMP, sodium EDTMP, sodium chitosan methylene phosphonate, sodium hexametaphosphate, sodium metaphosphate, potassium polyphosphate, sodium polyphosphate, sodium trimetaphosphate, sodium dihydroxyethylglycinate, potassium gluconate, sodium gluconate, sodium glucopeptate, sodium glycereth-1 polyphosphate, tetrapotassium pyrophosphate, triethanolamine polyphosphate (TEA), tetrasodium pyrophosphate, trisodium phosphate, potassium tripho sphonomethylamine oxide, sodium metasilicate, sodium phytate, sodium polydimethylglycinophenolsulfonate, tetrahydroxyethyl ethylene diamine, tetrahydroxypropyl ethylene diamine, tetrapotassium etidronate, tetrasodium etidronate, tetrasodium iminodisuccinate, trisodium ethylenediamine disuccinate, ethanolamine N,N-diacetic acid, disodium acetate, dimercaprol, deferoxamine, Zylox, and combinations of two or more thereof. Additional iron chelating agent include those disclosed and/or claimed in the international patent application WO 94/61338, which is incorporated herein in its entirety for all purposes.
Examples of biological chelating agents include metallothionein, transferrin, calmodulin, and sodium chitosan methylene phosphonatc.
[0080] The home care composition may include one or more pH adjusters to increase or decrease the overall pH of the home care composition. For example, one or more acids may be included to decrease the pH of the home care composition. Examples of suitable acids for decreasing the pH of the home care composition include, but are not limited to, citric acid, acetic acid, and the like. The home care composition may include one or more bases, such as sodium hydroxide, potassium hydroxide and the like, to increase the pH of the home care composition. Additional or alternative acids and bases that are suitable for adjusting the pH of the home care composition are readily known to one of ordinary skill in the art.
EXAMPLES
Example 1
[0081] Seven compositions were prepared in the form of a surface cleaner according to aspects of the invention. Two non-limiting example compositions (Ex. A and Ex. B) were formulated to contain two alpha hydroxy acids, namely lactic acid and citric acid. Five comparative compositions (Comp. Ex. 1 to Comp. Ex. 5) were formulated to contain one alpha hydroxy acid, specifically lactic acid or citric acid. Example Comp. A and Comp. B and Comp. Ex. 1 to Comp. Ex. 5 included caustic soda in an amount to obtain a pH of 3 to 3.5 for the respective home care composition. The formulations for Ex. A and Ex. B and Comp. Ex. 1 to Comp. Ex. 5 are shown in Table 1.
Example 2
[0082] Ex. A and Ex. B and Comp. Ex. 1 to Comp. Ex 5 were evaluated to assess the microbial growth of bacteria within each composition. Specifically, Ex. A and Ex. B and Comp. Ex. 1 to Comp. Ex. 5 were evaluated using a standard Micro Robustness test and expressed on a Micro Robustness Index (“MRI”). The MRI test evaluated the microbial growth of standard bacteria pool containing: Burkholderia cepacia ATCC 10856; Enterobacter cloacae PLS 237; Escherichia coli ATCC 8739; Klebsiella oxytoca PLS 104B; Klebsiella pneumoniae PLS 113; Serratia marcescens PLS 201; Providencia rettgeri PLS 200; Pseudomonas aeruginosa ATCC 15442; Pseudomonas putida PLS 111; Staphylococcus aureus ATCC 6538; and Staphylococcus saprophyticus PLS 110B. For liquids, a 9 gram sample of each of Ex. A, Ex. B and Comp. Ex. 1 to Comp. Ex. 5 was inoculated by adding 1.0 mL of the bacteria inoculum at time 0 hours (first inoculation). Each inoculated sample was then thoroughly mixed using a sterile wooden stick or other sterile stirrer. A MRI value of 0.85 or greater is generally considered to be robust and, thus, suitable for home care compositions.
[0083] The results of the Micro Robustness Index evaluation are shown in FIGS. 1-3. Notably, Ex. A and Ex. B exhibited an MRI value that was greater than the expected additive effect of the respective amounts of citric acid and lactic acid.
Claims
1. A home care composition comprising: a preservative system comprising an alpha hydroxy acid and/or a salt thereof; and from about 1 to about 25 wt.% of a surfactant system comprising:
(i) an anionic surfactant,
(ii) a non-ionic surfactant, and
(iii) optionally, an amphoteric surfactant, wherein the home care composition has a Micro Robustness Index value of 0.85 or greater, and all weight percentages are based on the total weight of the home care composition.
2. A home care composition comprising: a preservative system comprising a plurality of alpha hydroxy acids and/or a salts thereof; and from about 1 to about 25 wt.% of a surfactant system comprising:
(i) an anionic surfactant,
(ii) a non-ionic surfactant, and
(iii) optionally, an amphoteric surfactant, wherein the home care composition has a Micro Robustness Index value of 0.85 or greater, and all weight percentages are based on the total weight of the home care composition.
3. The home care composition of claim 2, wherein the plurality of alpha hydroxy acids and/or a salts thereof is selected from levulinic acid, lactic acid, glycolic acid, malic acid, tartaric acid, citric acid, a salt thereof, and a combination of two or more thereof.
4. The home care composition of any preceding claim, wherein the preservative system comprises lactic acid and/or a salt thereof and citric acid and/or a salt thereof.
5. The home care composition of claim 4, wherein the home care composition has a weight ratio of the lactic acid and/or the salt thereof to the citric acid and/or the salt thereof of from about
3: 1 to about 1 :5, optionally wherein the weight ratio of the lactic acid and/or the salt thereof to the citric acid and/or the salt thereof is from 1:1 to 1:2.
6. The home care composition of any preceding claim, wherein the preservative system comprises lactic acid and/or salt thereof in an amount from about 0.05 wt.% to 1.5 wt.%.
7. The home care composition of any preceding claim, wherein the preservative system comprises citric acid and/or salt thereof in an amount from about 0.05 wt.% to 1.5 wt.%.
8. The home care composition of any preceding claim, wherein the home care composition is free of glutaraldehyde.
9. The home care composition of any preceding claim, wherein the anionic surfactant comprises sodium laureth sulfate, ammonium laureth sulfate, disodium lauryl sulfosuccinate, disodium laureth sulfosuccinate, diammonium lauryl sulfosuccinate, diethylhexyl sodium sulfosuccinate, sodium oleyl succinate, sodium lauroyl methyl isethionate, sodium lauryl isethionate, sodium cocoyl isethionate, sodium laureth-5 carboxylate, lauryl ether carboxylic acid, ammonium lauryl sulfate, triethylamine lauryl sulfate, triethylamine laureth sulfate, triethanolamine lauryl sulfate, triethanolamine laureth sulfate, monoethanolamine lauryl sulfate, monoethanolamine laureth sulfate, diethanolamine lauryl sulfate, diethanolamine laureth sulfate, lauric monoglyceride sodium sulfate, sodium lauryl sulfate, potassium lauryl sulfate, potassium laureth sulfate, ammonium cocoyl sulfate, ammonium lauroyl sulfate, sodium cocoyl sulfate, sodium lauroyl sulfate, potassium cocoyl sulfate, monoethanolamine cocoyl sulfate, sodium tridecyl benzene sulfonate, sodium dodecyl benzene sulfonate, sodium C14-C16 olefin sulfonate, sodium lauryl sarcosinate, sodium lauroyl sarcosinate, stearoyl sarcosine, lauryl sarcosine, cocoyl sarcosine, sodium methyl cocoyl taurate, sodium methyl lauroyl taurate, sodium lauroyl glutamate, sodium cocoyl glutamate, disodium cocoyl glutamate, potassium myristoyl glutamate, TEA- cocoyl glutamate, sodium cocoyl glycinate, potassium cocoyl glycinate, sodium cocoyl alaninate, TEA-cocoyl alaninate, or a combination of two or more thereof.
10. The home care composition of claim 9, wherein the anionic surfactant comprises
disodium lauryl sulfosuccinate, disodium laureth sulfosuccinate, diammonium lauryl sulfosuccinatc, dicthylhcxyl sodium sulfosuccinatc, sodium oleyl succinate, sodium lauroyl methyl isethionate, sodium lauryl isethionate, sodium cocoyl isethionate, sodium laureth-5 carboxylate, lauryl ether carboxylic acid, sodium tridecyl benzene sulfonate, sodium dodecyl benzene sulfonate, sodium C14-C16 olefin sulfonate, sodium lauryl sarcosinate, sodium lauroyl sarcosinate, stearoyl sarcosine, lauryl sarcosine, cocoyl sarcosine, sodium methyl cocoyl taurate, sodium methyl lauroyl taurate, sodium lauroyl glutamate, sodium cocoyl glutamate, disodium cocoyl glutamate, potassium myristoyl glutamate, TEA-cocoyl glutamate, sodium cocoyl glycinate, potassium cocoyl glycinate, sodium cocoyl alaninate, TEA-cocoyl alaninate, or a combination of two or more thereof.
11. The home care composition of claim 9, wherein the anionic surfactant comprises sodium laureth sulfate, ammonium laureth sulfate, ammonium lauryl sulfate, triethylamine lauryl sulfate, triethylamine laureth sulfate, triethanolamine lauryl sulfate, triethanolamine laureth sulfate, monoethanolamine lauryl sulfate, monoethanolamine laureth sulfate, diethanolamine lauryl sulfate, diethanolamine laureth sulfate, lauric monoglyceride sodium sulfate, sodium lauryl sulfate, potassium lauryl sulfate, potassium laureth sulfate, ammonium cocoyl sulfate, ammonium lauroyl sulfate, sodium cocoyl sulfate, sodium lauroyl sulfate, potassium cocoyl sulfate, monoethanolamine cocoyl sulfate, or a combination of two or more thereof.
12. The home care composition of any preceding claim, wherein the non-ionic surfactant comprises a polyglycoside, alkoxylated fatty alcohols, alkyl(ether)phosphates, alkyl phosphate esters, or a combination of two or more thereof, optionally wherein the non-ionic surfactant comprises an alky polyglycoside, further optionally wherein the alkyl polyglycoside has at least one C8-C22 alkyl group,
13. The home care composition of claim 12, wherein the polyglycoside is an alkyl polyglycoside having C10-C15 alkyl groups.
14. The home care composition of claim 12, wherein the polyglycoside comprises decyl glucoside.
15. The home care composition of claim 12, wherein the alkoxylatcd fatty alcohol is selected from a di-alkyl alkoxylatcd fatty alcohol polymer, a tri-alkyl alkoxylatcd fatty alcohol polymer, and a combination of two or more thereof.
16. The home care composition of claim 12, wherein the alkoxylatcd alkyl phosphate esters comprises PPG-5-ceteth-10 phosphate, oleth-3 phosphate, oleth-10 phosphate, ceteth-10 phosphate, dicetyl phosphate, cetyl phosphate, stearyl phosphate, or a combination of two or more thereof.
17. The home care composition of any preceding claim comprising an amphoteric surfactant selected from betaines, sultaines, amphoacetates, amphoproprionates, or a combination of two or more thereof.
18. The home care composition of claim 16, wherein the amphoteric surfactant is selected from C8-C20 alkylbetaines, C8-C20 alkylamido(Ci-C6)alkylbetaines, sulfobetaines, C8-C20 alkylsulfobetaines, C8-C20 alkylamido(Ci-C6)alkylsulfobetaines, C8-C 0 alkylamphoacetate, Cx- C20 alkylamphodiacetate, a salt thereof, and a combination of two or more thereof.
19. The home care composition of any preceding claim further comprising from about 0.1 to about 20 wt.% of a thickening agent, optionally wherein the thickening agent comprises an acrylate polymer, a polymeric gum, a polysaccharide, a microfibrous cellulose, a gellan gum, a pectine, an alginate, an arabinogalactan, a carageenan, a xanthum gum, a guar gum, a rhamsan gum, a furcellaran gum, or a combination of two or more thereof.
20. The home care composition of claim 24, wherein the acrylate polymer is selected from polyacrylates, methacrylates, crosslinked acrylic acid polymers, and a combination of two or more thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263433071P | 2022-12-16 | 2022-12-16 | |
US63/433,071 | 2022-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024130110A1 true WO2024130110A1 (en) | 2024-06-20 |
Family
ID=89662236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2023/084275 WO2024130110A1 (en) | 2022-12-16 | 2023-12-15 | Home care compositions |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024130110A1 (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4051234A (en) | 1975-06-06 | 1977-09-27 | The Procter & Gamble Company | Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies |
US6495506B1 (en) * | 2000-02-11 | 2002-12-17 | Colgate-Palmolive Company | Acidic all purpose liquid cleaning compositions |
US20100056416A1 (en) * | 2008-08-26 | 2010-03-04 | Scheuing David R | Natural cleaners |
US20110180101A1 (en) * | 2010-01-25 | 2011-07-28 | The Dial Corporation | Multi-surface acidic bathroom cleaning system |
US20140336094A1 (en) * | 2013-05-08 | 2014-11-13 | Basf Se | Cleaning composition and method of forming the same |
DE102014224747A1 (en) * | 2014-12-03 | 2016-06-09 | Henkel Ag & Co. Kgaa | enzyme stabilizers |
US20170319450A1 (en) * | 2014-12-01 | 2017-11-09 | Colgate-Palmolive Company | Increasing Micro-Robustness |
US20170333330A1 (en) * | 2014-12-18 | 2017-11-23 | Colgate-Palmolive Company | Oral Care Compositions Having High Water Content and Micro Robustness |
WO2023114704A1 (en) * | 2021-12-16 | 2023-06-22 | Colgate-Palmolive Company | Home care compositions |
-
2023
- 2023-12-15 WO PCT/US2023/084275 patent/WO2024130110A1/en unknown
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4051234A (en) | 1975-06-06 | 1977-09-27 | The Procter & Gamble Company | Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies |
US6495506B1 (en) * | 2000-02-11 | 2002-12-17 | Colgate-Palmolive Company | Acidic all purpose liquid cleaning compositions |
US20100056416A1 (en) * | 2008-08-26 | 2010-03-04 | Scheuing David R | Natural cleaners |
US20110180101A1 (en) * | 2010-01-25 | 2011-07-28 | The Dial Corporation | Multi-surface acidic bathroom cleaning system |
US20140336094A1 (en) * | 2013-05-08 | 2014-11-13 | Basf Se | Cleaning composition and method of forming the same |
US20170319450A1 (en) * | 2014-12-01 | 2017-11-09 | Colgate-Palmolive Company | Increasing Micro-Robustness |
DE102014224747A1 (en) * | 2014-12-03 | 2016-06-09 | Henkel Ag & Co. Kgaa | enzyme stabilizers |
US20170333330A1 (en) * | 2014-12-18 | 2017-11-23 | Colgate-Palmolive Company | Oral Care Compositions Having High Water Content and Micro Robustness |
WO2023114704A1 (en) * | 2021-12-16 | 2023-06-22 | Colgate-Palmolive Company | Home care compositions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60030544T2 (en) | LIQUID ALL-PURPOSE CLEANER FOR BATHROOM | |
US4595526A (en) | High foaming nonionic surfacant based liquid detergent | |
PT99209A (en) | PROCESS FOR THE PREPARATION OF PERSONAL CLEANING COMPOSITIONS COMPOSING ANIONIC AND ANFOTERIC TENSIOACTIVE AGENTS AND A VEGETABLE OIL ADUCT | |
KR20170083604A (en) | Shampoos and conditioners having a conditioning effect | |
KR20020052216A (en) | Stable, High Glycerol Liquids Comprising N-Acyl Amino Acids and/or Salts | |
US6479442B1 (en) | Hydrotrope and skin conditioning agents for use in liquid detergent compositions | |
BRPI0611472A2 (en) | biphasic liquid product composition, biphasic liquid personal product composition and process of increasing viscosity of aqueous / aqueous biphasic liquid compositions | |
WO2008046778A1 (en) | Manual dishwashing detergent with improved oil solubilization | |
WO2018065190A1 (en) | Personal wash disinfectant liquid | |
US20230193156A1 (en) | Home care compositions | |
EP4210836A1 (en) | Novel use of saccharide isomerate | |
JP5204389B2 (en) | Liquid disinfectant cleaning composition | |
JP6694343B2 (en) | Skin cleanser composition | |
AU663186B2 (en) | High foaming nonionic surfactant based liquid detergent | |
AU730992B2 (en) | Liquid compositions comprising stability enhancing surfactants and a method of enhancing low temperature stability thereof | |
AU2002342563A1 (en) | Mixed polyalkylene glycol hydroxyalkyl isostearamides as rheology adjuvants | |
EP1395644A1 (en) | Mixed polyalkylene glycol hydroxyalkyl isostearamides as rheology adjuvants | |
JP5669522B2 (en) | Liquid detergent composition in former container | |
CA3179813A1 (en) | Naturally derived surfactant system and composition comprising the same | |
WO2024130110A1 (en) | Home care compositions | |
WO1998002512A2 (en) | High foaming nonionic surfactant based liquid detergent | |
WO2003050228A1 (en) | Antibacterial cleaning wipe | |
JP2000511914A (en) | Aqueous pearlescent concentrate | |
ES2535754T3 (en) | Rheology modifier for aqueous surfactant based formulations | |
JPH0474102A (en) | External bactericide composition and cutaneous detergent composition |